| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B MYH3 ERCC3 SETX ERCC6 MYH13 MYO1C ATAD5 NAIP ABCB1 ABCB4 MYO3A STARD9 ABCD4 ABCC2 DHX29 DNAH8 ABCC1 HYOU1 FANCM ATF7IP ABCB8 ABCB11 ACIN1 MACF1 MYH15 | 5.07e-08 | 614 | 247 | 26 | GO:0140657 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.13e-07 | 5 | 247 | 4 | GO:0030156 | |
| GeneOntologyMolecularFunction | actin binding | MYH3 MYH13 MYO1C TMOD2 ITPRID2 ADD3 MYO3A PLEKHH2 MLPH UTRN FLNC MYRIP LMOD2 YWHAH GSN MICALL2 MACF1 MYH15 CTNNA1 CTNNA2 SNTB1 | 5.97e-07 | 479 | 247 | 21 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B MYH3 PDE4B MYH13 MYO1C TMOD2 ITPRID2 ADGRV1 DYSF ADD3 DRG1 PPARGC1A MYO3A STARD9 YWHAQ PLEKHH2 USH2A MLPH UTRN FLNC ANK2 MYRIP LMTK2 EPB41L5 LMOD2 YWHAH GSN MICALL2 MACF1 MYH15 CTNNA1 CTNNA2 SNTB1 HTT | 7.81e-07 | 1099 | 247 | 34 | GO:0008092 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.25e-06 | 49 | 247 | 7 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B MYH3 ERCC3 ERCC6 ATAD5 NAIP ABCB1 ABCB4 ABCD4 ABCC2 DHX29 DNAH8 ABCC1 FANCM ATF7IP ABCB8 ABCB11 ACIN1 MACF1 | 2.70e-06 | 441 | 247 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | actin filament binding | MYH3 MYH13 MYO1C ITPRID2 ADD3 MYO3A FLNC GSN MICALL2 MACF1 MYH15 CTNNA1 CTNNA2 | 5.36e-06 | 227 | 247 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 2.80e-05 | 15 | 247 | 4 | GO:0008559 | |
| GeneOntologyMolecularFunction | small GTPase binding | GGA2 MYO1C PIH1D2 ITPKA MLPH DMXL2 CCDC186 MYRIP ARHGAP1 MICALL2 SYTL5 AKAP13 GGA1 RAB11FIP3 | 5.00e-05 | 321 | 247 | 14 | GO:0031267 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.00e-04 | 38 | 247 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B MYH3 ERCC3 ERCC6 ATAD5 NAIP ABCB1 ABCB4 DRG1 ABCD4 ABCC2 DHX29 DNAH8 ABCC1 ARL15 FANCM RGS12 MTIF2 ATF7IP ABCB8 ABCB11 ACIN1 MACF1 | 1.01e-04 | 775 | 247 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.11e-04 | 118 | 247 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH3 MYH13 MYO1C ADD3 ITPKA MYO3A YWHAQ CNGA2 GRIN1 MYH15 SNTB1 | 1.44e-04 | 230 | 247 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | ABC-type vitamin B12 transporter activity | 1.52e-04 | 2 | 247 | 2 | GO:0015420 | |
| GeneOntologyMolecularFunction | GTPase binding | GGA2 MYO1C PIH1D2 ITPKA MLPH DMXL2 CCDC186 MYRIP ARHGAP1 MICALL2 SYTL5 AKAP13 GGA1 RAB11FIP3 | 1.68e-04 | 360 | 247 | 14 | GO:0051020 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B MYH3 ERCC3 ERCC6 ATAD5 NAIP ABCB1 ABCB4 DRG1 ABCD4 ABCC2 DHX29 DNAH8 ABCC1 ARL15 FANCM RGS12 MTIF2 ATF7IP ABCB8 ABCB11 ACIN1 MACF1 | 3.17e-04 | 839 | 247 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B MYH3 ERCC3 ERCC6 ATAD5 NAIP ABCB1 ABCB4 DRG1 ABCD4 ABCC2 DHX29 DNAH8 ABCC1 ARL15 FANCM RGS12 MTIF2 ATF7IP ABCB8 ABCB11 ACIN1 MACF1 | 3.23e-04 | 840 | 247 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B MYH3 ERCC3 ERCC6 ATAD5 NAIP ABCB1 ABCB4 DRG1 ABCD4 ABCC2 DHX29 DNAH8 ABCC1 ARL15 FANCM RGS12 MTIF2 ATF7IP ABCB8 ABCB11 ACIN1 MACF1 | 3.23e-04 | 840 | 247 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 3.79e-04 | 12 | 247 | 3 | GO:0050815 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 4.16e-04 | 109 | 247 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 4.53e-04 | 3 | 247 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | endoplasmic reticulum-organelle membrane tether activity | 4.53e-04 | 3 | 247 | 2 | GO:0170009 | |
| GeneOntologyMolecularFunction | endoplasmic reticulum-autophagosome adaptor activity | 4.53e-04 | 3 | 247 | 2 | GO:0140506 | |
| GeneOntologyMolecularFunction | autophagosome-membrane adaptor activity | 4.53e-04 | 3 | 247 | 2 | GO:0160183 | |
| GeneOntologyMolecularFunction | myosin binding | 6.52e-04 | 85 | 247 | 6 | GO:0017022 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 7.92e-04 | 34 | 247 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 9.00e-04 | 4 | 247 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.82e-03 | 20 | 247 | 3 | GO:0046624 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 1.55e-05 | 5 | 241 | 3 | GO:0099039 | |
| GeneOntologyBiologicalProcess | xenobiotic transport across blood-brain barrier | 3.07e-05 | 6 | 241 | 3 | GO:1990962 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | HECW1 TMEM74 DYSF ABCB1 KCNS1 UTRN CACNB3 ANK2 YWHAH HTT JPH3 NOS1AP | 5.10e-05 | 256 | 241 | 12 | GO:0032412 |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 RIPOR2 DZIP1L BECN2 TMOD2 DRG1 FSIP2 NRXN2 STARD9 CFAP70 YWHAQ DHX29 DNAH8 CFAP47 FLNC RPGRIP1L LMOD2 CDCA8 TTLL8 CEP164 GSN DNAAF2 ATG3 STYXL1 AKAP13 LRBA WIPI2 HTT RAB11FIP3 | 6.75e-05 | 1138 | 241 | 29 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | HECW1 TMEM74 DYSF ABCB1 KCNS1 UTRN CACNB3 ANK2 YWHAH HTT JPH3 NOS1AP | 7.37e-05 | 266 | 241 | 12 | GO:0022898 |
| GeneOntologyBiologicalProcess | neuron development | EPHB6 RIPOR2 SETX ERCC6 PSD HECW1 SYT17 FSTL4 LAMC3 ADGRV1 RETREG3 ITPKA SYNGAP1 MYO3A TRPM1 NOTCH3 RPGRIP1L DSCAM LMTK2 LAMB1 RAPGEF1 GRIN1 YWHAH YWHAZ FRY MICALL2 STYXL1 UNK MACF1 CTNNA1 CTNNA2 LGR6 INPP5J HTT | 9.51e-05 | 1463 | 241 | 34 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | PDE4B HECW1 TMEM74 DYSF ABCB1 KCNS1 YWHAQ UTRN CACNB3 ANK2 GRIN1 YWHAH HTT JPH3 NOS1AP | 1.24e-04 | 417 | 241 | 15 | GO:0034765 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor catabolic process | 1.36e-04 | 2 | 241 | 2 | GO:1990172 | |
| GeneOntologyBiologicalProcess | negative regulation of Rho guanyl-nucleotide exchange factor activity | 1.36e-04 | 2 | 241 | 2 | GO:2001107 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | TMOD2 DYSF ADD3 PPARGC1A YWHAQ PLEKHH2 CLEC16A SMG6 LMOD2 CDCA8 GSN ZWINT STYXL1 CTNNA2 INPP5J | 1.38e-04 | 421 | 241 | 15 | GO:0010639 |
| GeneOntologyCellularComponent | stereocilium membrane | 2.89e-07 | 6 | 249 | 4 | GO:0060171 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 2.36e-06 | 9 | 249 | 4 | GO:0046581 | |
| GeneOntologyCellularComponent | cell leading edge | RIPOR2 PSD MYO1C ADGRV1 DYSF FAT1 RIPOR1 PLEKHH2 USH2A EPB41L5 GRIN1 YWHAZ GSN ARHGAP1 MACF1 CTNNA1 CTNNA2 ARHGAP45 SNX2 INPP5J | 2.58e-06 | 500 | 249 | 20 | GO:0031252 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH3 MYH13 MYO1C TMOD2 DGKH ITPKA MYO3A PLEKHH2 MLPH FLNC MYRIP LMOD2 GSN MICALL2 LPP MACF1 MYH15 AKAP13 CTNNA1 CTNNA2 NOS1AP | 6.09e-06 | 576 | 249 | 21 | GO:0015629 |
| GeneOntologyCellularComponent | myosin complex | 7.15e-05 | 59 | 249 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | leading edge membrane | RIPOR2 PSD MYO1C ADGRV1 USH2A EPB41L5 GRIN1 MACF1 ARHGAP45 INPP5J | 2.22e-04 | 210 | 249 | 10 | GO:0031256 |
| GeneOntologyCellularComponent | anchoring junction | ADD3 ABCB1 ABCB4 KIAA1210 FAT1 YWHAQ ABCC2 FLNC RPGRIP1L HYOU1 ANK2 EPB41L5 YWHAB YWHAG YWHAH YWHAZ GSN FRMD4A MICALL2 LPP ABCB11 CTNNA1 CTNNA2 SNTB1 NOS1AP | 2.76e-04 | 976 | 249 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | manchette | 3.21e-04 | 28 | 249 | 4 | GO:0002177 | |
| GeneOntologyCellularComponent | basal ectoplasmic specialization | 4.21e-04 | 3 | 249 | 2 | GO:0061832 | |
| GeneOntologyCellularComponent | cell projection membrane | RIPOR2 PSD MYO1C ADGRV1 PTH1R ABCC2 USH2A UTRN CNGA2 EPB41L5 GRIN1 MACF1 ARHGAP45 INPP5J | 7.03e-04 | 431 | 249 | 14 | GO:0031253 |
| GeneOntologyCellularComponent | USH2 complex | 8.35e-04 | 4 | 249 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | intracellular canaliculus | 1.38e-03 | 5 | 249 | 2 | GO:0046691 | |
| GeneOntologyCellularComponent | stereocilium | 1.39e-03 | 69 | 249 | 5 | GO:0032420 | |
| GeneOntologyCellularComponent | ruffle membrane | 1.87e-03 | 108 | 249 | 6 | GO:0032587 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | NCOA3 PDE4B CHGA ADGRV1 FBXL5 FAT1 KCNS1 YWHAQ DOCK6 MLPH ANK2 MYRIP LMTK2 LAMB1 RAPGEF1 YWHAB YWHAZ GSN ARHGAP1 AKAP13 HTT NOS1AP | 1.88e-03 | 934 | 249 | 22 | GO:0048471 |
| GeneOntologyCellularComponent | cell-cell junction | ADD3 ABCB1 ABCB4 KIAA1210 FAT1 ABCC2 RPGRIP1L ANK2 EPB41L5 YWHAH GSN FRMD4A MICALL2 ABCB11 CTNNA1 CTNNA2 | 2.03e-03 | 591 | 249 | 16 | GO:0005911 |
| GeneOntologyCellularComponent | sarcolemma | 2.05e-03 | 190 | 249 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 2.05e-03 | 6 | 249 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 2.05e-03 | 6 | 249 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 2.05e-03 | 6 | 249 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | ATP-binding cassette (ABC) transporter complex | 2.05e-03 | 6 | 249 | 2 | GO:0043190 | |
| GeneOntologyCellularComponent | focal adhesion | ABCB4 FAT1 YWHAQ FLNC HYOU1 EPB41L5 YWHAB YWHAG YWHAZ GSN LPP CTNNA1 SNTB1 | 2.09e-03 | 431 | 249 | 13 | GO:0005925 |
| GeneOntologyCellularComponent | apical plasma membrane | ERBB3 RIPOR2 PTH1R ABCB1 ABCB4 FAT1 ABCC2 USH2A ABCC1 CACNB3 ANK2 MYRIP SLC12A1 ABCB11 | 2.22e-03 | 487 | 249 | 14 | GO:0016324 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.29e-03 | 238 | 249 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | stereocilium bundle | 2.54e-03 | 79 | 249 | 5 | GO:0032421 | |
| GeneOntologyCellularComponent | cell-substrate junction | ABCB4 FAT1 YWHAQ FLNC HYOU1 EPB41L5 YWHAB YWHAG YWHAZ GSN LPP CTNNA1 SNTB1 | 2.65e-03 | 443 | 249 | 13 | GO:0030055 |
| GeneOntologyCellularComponent | nuclear body | RAD18 SETX ERCC6 MYO1C REXO1 DRG1 PPARGC1A TONSL PLEKHH2 ADGRD1 ZCCHC18 ZCCHC8 RNF34 E4F1 VIRMA PPP4R3A ZWINT ATF7IP CHFR SAFB2 ACIN1 | 2.77e-03 | 903 | 249 | 21 | GO:0016604 |
| MousePheno | abnormal retina morphology | SETX ERCC6 WDR81 LAMC3 UROC1 BIRC6 FSCB PTH1R RETREG3 RPS6KC1 PPARGC1A FREM2 FAT1 ALDH16A1 TONSL KATNIP TRPM1 YWHAQ CHPF USH2A NOTCH3 PRIMPOL IMPG2 RETREG2 DSCAM EPB41L5 RAPGEF1 YWHAB YWHAZ TGFBI FRMD4A LPP ABCB11 MACF1 AKAP13 CTNNA1 WIPI2 NOS1AP | 9.38e-06 | 1227 | 207 | 38 | MP:0001325 |
| MousePheno | abnormal ocular fundus morphology | SETX ERCC6 WDR81 LAMC3 UROC1 BIRC6 FSCB PTH1R RETREG3 RPS6KC1 PPARGC1A FREM2 FAT1 ALDH16A1 TONSL KATNIP TRPM1 YWHAQ CHPF USH2A NOTCH3 PRIMPOL IMPG2 RETREG2 DSCAM EPB41L5 RAPGEF1 YWHAB YWHAZ TGFBI FRMD4A LPP ABCB11 MACF1 AKAP13 CTNNA1 WIPI2 NOS1AP | 1.78e-05 | 1262 | 207 | 38 | MP:0002864 |
| Domain | 14_3_3 | 7.51e-09 | 7 | 244 | 5 | SM00101 | |
| Domain | 1433_1 | 7.51e-09 | 7 | 244 | 5 | PS00796 | |
| Domain | 1433_2 | 7.51e-09 | 7 | 244 | 5 | PS00797 | |
| Domain | 14-3-3_domain | 7.51e-09 | 7 | 244 | 5 | IPR023410 | |
| Domain | 14-3-3_CS | 7.51e-09 | 7 | 244 | 5 | IPR023409 | |
| Domain | 14-3-3 | 7.51e-09 | 7 | 244 | 5 | PF00244 | |
| Domain | 14-3-3 | 1.98e-08 | 8 | 244 | 5 | IPR000308 | |
| Domain | ABC_TM1F | 5.58e-08 | 28 | 244 | 7 | PS50929 | |
| Domain | ABC1_TM_dom | 5.58e-08 | 28 | 244 | 7 | IPR011527 | |
| Domain | ABC_membrane | 5.17e-07 | 24 | 244 | 6 | PF00664 | |
| Domain | ABC_transporter_CS | 1.09e-06 | 42 | 244 | 7 | IPR017871 | |
| Domain | ABC_tran | 2.78e-06 | 48 | 244 | 7 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.78e-06 | 48 | 244 | 7 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 3.21e-06 | 49 | 244 | 7 | PS00211 | |
| Domain | ABC_transporter-like | 3.69e-06 | 50 | 244 | 7 | IPR003439 | |
| Domain | P-loop_NTPase | KIF21B MYH3 ERCC3 SETX ERCC6 MYH13 MYO1C ATAD5 NAIP ABCB1 ABCB4 DRG1 MYO3A STARD9 AK5 ABCD4 ABCC2 DHX29 DNAH8 ABCC1 CACNB3 ARL15 FANCM RABL6 MTIF2 ABCB8 ABCB11 MYH15 | 6.49e-06 | 848 | 244 | 28 | IPR027417 |
| Domain | SAP | 1.57e-05 | 25 | 244 | 5 | PS50800 | |
| Domain | SAP_dom | 1.57e-05 | 25 | 244 | 5 | IPR003034 | |
| Domain | AAA | 2.00e-05 | 144 | 244 | 10 | SM00382 | |
| Domain | AAA+_ATPase | 2.00e-05 | 144 | 244 | 10 | IPR003593 | |
| Domain | ARM-like | MON2 DCAF1 GPRASP1 RIPOR2 SETX RIPOR1 BRAT1 RANBP6 PPP4R3A PELP1 INTS4 LRBA HTT | 5.87e-05 | 270 | 244 | 13 | IPR011989 |
| Domain | Reticulon | 7.42e-05 | 7 | 244 | 3 | PF02453 | |
| Domain | Reticulon | 1.18e-04 | 8 | 244 | 3 | IPR003388 | |
| Domain | Myosin_head_motor_dom | 1.29e-04 | 38 | 244 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.29e-04 | 38 | 244 | 5 | PS51456 | |
| Domain | Myosin_head | 1.29e-04 | 38 | 244 | 5 | PF00063 | |
| Domain | MYSc | 1.29e-04 | 38 | 244 | 5 | SM00242 | |
| Domain | - | 1.43e-04 | 21 | 244 | 4 | 1.10.720.30 | |
| Domain | ARM-type_fold | MON2 DCAF1 GPRASP1 RIPOR2 RIPOR1 BRAT1 RANBP6 VIRMA PPP4R3A MROH8 PELP1 INTS4 LRBA HTT | 1.57e-04 | 339 | 244 | 14 | IPR016024 |
| Domain | ZF_FYVE | 1.65e-04 | 40 | 244 | 5 | PS50178 | |
| Domain | Myrip/Melanophilin | 1.70e-04 | 2 | 244 | 2 | IPR006788 | |
| Domain | Rab_eff_C | 1.70e-04 | 2 | 244 | 2 | PF04698 | |
| Domain | SAP | 1.73e-04 | 22 | 244 | 4 | PF02037 | |
| Domain | SAP | 2.07e-04 | 23 | 244 | 4 | SM00513 | |
| Domain | FYVE_2 | 3.36e-04 | 11 | 244 | 3 | PF02318 | |
| Domain | FN3_dom | EPHB6 TSPOAP1 RIMBP3C USH2A COL6A3 FLNC DSCAM RIMBP3 ATF7IP RIMBP3B | 4.39e-04 | 209 | 244 | 10 | IPR003961 |
| Domain | RABBD | 4.44e-04 | 12 | 244 | 3 | PS50916 | |
| Domain | Rab_BD | 4.44e-04 | 12 | 244 | 3 | IPR010911 | |
| Domain | - | DCAF1 KIF21B CFAP251 FSTL5 FSTL4 WDR81 ARHGEF17 BIRC6 DMXL2 DCAF8L2 WDR73 LRBA WIPI2 | 4.60e-04 | 333 | 244 | 13 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DCAF1 KIF21B CFAP251 FSTL5 FSTL4 WDR81 ARHGEF17 BIRC6 DMXL2 DCAF8L2 WDR73 LRBA WIPI2 | 4.87e-04 | 335 | 244 | 13 | IPR015943 |
| Domain | PIH1 | 5.06e-04 | 3 | 244 | 2 | PF08190 | |
| Domain | PIH1 | 5.06e-04 | 3 | 244 | 2 | IPR012981 | |
| Domain | PL48 | 5.06e-04 | 3 | 244 | 2 | PF15903 | |
| Domain | FAM65_N | 5.06e-04 | 3 | 244 | 2 | IPR031780 | |
| Domain | CSRNP_N | 5.06e-04 | 3 | 244 | 2 | IPR031972 | |
| Domain | FAM65 | 5.06e-04 | 3 | 244 | 2 | IPR026136 | |
| Domain | Cys/Ser-rich_nuc_prot | 5.06e-04 | 3 | 244 | 2 | IPR023260 | |
| Domain | CSRNP_N | 5.06e-04 | 3 | 244 | 2 | PF16019 | |
| Domain | - | MON2 DCAF1 GPRASP1 RIPOR2 RIPOR1 BRAT1 RANBP6 INTS4 LRBA HTT | 7.03e-04 | 222 | 244 | 10 | 1.25.10.10 |
| Domain | - | ERCC3 SETX ERCC6 ATAD5 NAIP ABCB1 ABCB4 DRG1 AK5 ABCD4 ABCC2 DHX29 DNAH8 ABCC1 CACNB3 ARL15 FANCM RABL6 MTIF2 ABCB8 ABCB11 | 8.22e-04 | 746 | 244 | 21 | 3.40.50.300 |
| Domain | Myosin_N | 8.92e-04 | 15 | 244 | 3 | PF02736 | |
| Domain | Myosin_N | 8.92e-04 | 15 | 244 | 3 | IPR004009 | |
| Domain | SH3_2 | 9.19e-04 | 86 | 244 | 6 | PF07653 | |
| Domain | SH3_2 | 9.19e-04 | 86 | 244 | 6 | IPR011511 | |
| Domain | Alpha_catenin | 1.00e-03 | 4 | 244 | 2 | IPR001033 | |
| Domain | VINCULIN_1 | 1.00e-03 | 4 | 244 | 2 | PS00663 | |
| Domain | Vinculin_CS | 1.00e-03 | 4 | 244 | 2 | IPR000633 | |
| Domain | Multidrug-R_assoc | 1.00e-03 | 4 | 244 | 2 | IPR005292 | |
| Domain | Laminin_N | 1.09e-03 | 16 | 244 | 3 | IPR008211 | |
| Domain | LamNT | 1.09e-03 | 16 | 244 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 1.09e-03 | 16 | 244 | 3 | PS51117 | |
| Domain | Laminin_N | 1.09e-03 | 16 | 244 | 3 | PF00055 | |
| Domain | FN3 | EPHB6 TSPOAP1 RIMBP3C USH2A COL6A3 DSCAM RIMBP3 ATF7IP RIMBP3B | 1.25e-03 | 199 | 244 | 9 | PS50853 |
| Domain | Znf_FYVE | 1.48e-03 | 38 | 244 | 4 | IPR000306 | |
| Domain | PH_dom-like | PSD DGKH ARHGEF17 SYNGAP1 PLEKHH2 EPB41L5 DGKD RGS12 PPP4R3A FRMD4A AKAP13 LRBA SNTB1 NOS1AP | 1.50e-03 | 426 | 244 | 14 | IPR011993 |
| Domain | - | 1.54e-03 | 95 | 244 | 6 | 2.60.120.200 | |
| Domain | Myosin_tail_1 | 1.55e-03 | 18 | 244 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.55e-03 | 18 | 244 | 3 | IPR002928 | |
| Domain | C1 | 1.59e-03 | 65 | 244 | 5 | SM00109 | |
| Domain | GAE | 1.66e-03 | 5 | 244 | 2 | PS50180 | |
| Domain | Vinculin | 1.66e-03 | 5 | 244 | 2 | PF01044 | |
| Domain | RETICULON | 1.66e-03 | 5 | 244 | 2 | PS50845 | |
| Domain | PE/DAG-bd | 1.71e-03 | 66 | 244 | 5 | IPR002219 | |
| Domain | Myosin-like_IQ_dom | 1.83e-03 | 19 | 244 | 3 | IPR027401 | |
| Domain | - | 1.83e-03 | 19 | 244 | 3 | 4.10.270.10 | |
| Domain | - | PSD DGKH ARHGEF17 SYNGAP1 PLEKHH2 EPB41L5 DGKD RGS12 PPP4R3A FRMD4A AKAP13 SNTB1 NOS1AP | 1.98e-03 | 391 | 244 | 13 | 2.30.29.30 |
| Domain | CH | 2.22e-03 | 70 | 244 | 5 | PF00307 | |
| Domain | - | 2.36e-03 | 71 | 244 | 5 | 1.10.418.10 | |
| Domain | - | 2.46e-03 | 6 | 244 | 2 | 2.60.40.1230 | |
| Domain | GAT_dom | 2.46e-03 | 6 | 244 | 2 | IPR004152 | |
| Domain | - | 2.46e-03 | 6 | 244 | 2 | 1.20.58.160 | |
| Domain | Clathrin_g-adaptin_app | 2.46e-03 | 6 | 244 | 2 | IPR008153 | |
| Domain | GAT | 2.46e-03 | 6 | 244 | 2 | PS50909 | |
| Domain | GAT | 2.46e-03 | 6 | 244 | 2 | PF03127 | |
| Domain | CH | 2.66e-03 | 73 | 244 | 5 | PS50021 | |
| Domain | CH-domain | 3.00e-03 | 75 | 244 | 5 | IPR001715 | |
| Domain | FN3 | 3.05e-03 | 185 | 244 | 8 | SM00060 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 2.52e-09 | 46 | 165 | 9 | M239 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 1.53e-07 | 12 | 165 | 5 | MM14482 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 1.53e-07 | 12 | 165 | 5 | M45022 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 1.53e-07 | 12 | 165 | 5 | MM15443 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 2.47e-07 | 13 | 165 | 5 | M47589 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 2.47e-07 | 13 | 165 | 5 | M27708 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 2.67e-07 | 6 | 165 | 4 | M22078 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 5.65e-07 | 15 | 165 | 5 | M26902 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 7.05e-07 | 44 | 165 | 7 | M11911 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 8.14e-07 | 16 | 165 | 5 | M46428 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 1.57e-06 | 18 | 165 | 5 | MM14510 | |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 3.62e-06 | 21 | 165 | 5 | M48088 | |
| Pathway | PID_P38_MK2_PATHWAY | 3.62e-06 | 21 | 165 | 5 | M199 | |
| Pathway | REACTOME_APOPTOSIS | 4.81e-06 | 108 | 165 | 9 | MM14471 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 5.87e-06 | 23 | 165 | 5 | MM15216 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | TRADD TNFRSF10D YWHAQ YWHAB YWHAG YWHAH YWHAZ GSN ACIN1 IL1A | 6.47e-06 | 142 | 165 | 10 | MM15178 |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 8.33e-06 | 12 | 165 | 4 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 8.33e-06 | 12 | 165 | 4 | M27939 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 1.11e-05 | 26 | 165 | 5 | M247 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 1.55e-05 | 5 | 165 | 3 | MM1586 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | PPARGC1A YWHAQ GRIN1 YWHAB YWHAG YWHAH YWHAZ PPARGC1B IL1A NOS1AP | 1.75e-05 | 159 | 165 | 10 | M39373 |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 2.32e-05 | 30 | 165 | 5 | M17814 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 5.05e-05 | 35 | 165 | 5 | M249 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 5.81e-05 | 36 | 165 | 5 | M271 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 9.77e-05 | 40 | 165 | 5 | MM14473 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.12e-04 | 22 | 165 | 4 | MM15656 | |
| Pathway | PID_MTOR_4PATHWAY | 1.53e-04 | 69 | 165 | 6 | M121 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.94e-04 | 72 | 165 | 6 | M26954 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 1.94e-04 | 72 | 165 | 6 | MM15381 | |
| Pathway | PID_LKB1_PATHWAY | 2.13e-04 | 47 | 165 | 5 | M87 | |
| Pathway | PID_FOXO_PATHWAY | 2.60e-04 | 49 | 165 | 5 | M136 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 3.14e-04 | 51 | 165 | 5 | M7955 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 3.21e-04 | 12 | 165 | 3 | M48096 | |
| Pathway | WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT | 3.42e-04 | 29 | 165 | 4 | M45551 | |
| Pathway | PID_NFAT_3PATHWAY | 3.77e-04 | 53 | 165 | 5 | M113 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 3.91e-04 | 30 | 165 | 4 | MM15866 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 4.48e-04 | 55 | 165 | 5 | M7455 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 5.04e-04 | 32 | 165 | 4 | M39567 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 5.68e-04 | 33 | 165 | 4 | M39875 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 6.38e-04 | 34 | 165 | 4 | M16393 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 7.14e-04 | 35 | 165 | 4 | M39488 | |
| Pathway | WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER | 7.88e-04 | 16 | 165 | 3 | M39391 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 8.17e-04 | 94 | 165 | 6 | M1080 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 8.50e-04 | 211 | 165 | 9 | M27436 | |
| Pathway | WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY | 9.49e-04 | 17 | 165 | 3 | M39666 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.04e-03 | 66 | 165 | 5 | M27938 | |
| Pathway | PID_ATR_PATHWAY | 1.08e-03 | 39 | 165 | 4 | M46 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 1.11e-03 | 67 | 165 | 5 | M295 | |
| Pathway | REACTOME_APOPTOSIS | 1.22e-03 | 179 | 165 | 8 | M15303 | |
| Pathway | WP_FARNESOID_X_RECEPTOR_PATHWAY | 1.33e-03 | 19 | 165 | 3 | M39411 | |
| Pathway | WP_CHOLESTASIS | 1.33e-03 | 19 | 165 | 3 | M45520 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGEF17 ADD3 YWHAQ DOCK6 NUP160 RAPGEF1 CDCA8 YWHAB YWHAG YWHAH YWHAZ ZWINT ARHGAP1 AKAP13 CAVIN1 CTNNA1 ARHGAP45 | 1.58e-03 | 649 | 165 | 17 | MM15690 |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.64e-03 | 73 | 165 | 5 | MM15223 | |
| Pubmed | MON2 PRPSAP2 GPRASP1 HECW1 TSPOAP1 RTN3 BIRC6 RTN1 ADD3 RPS6KC1 SYNGAP1 SAFB YWHAQ SIPA1L2 DHX29 CLEC16A DMXL2 MIA3 ANK2 RETREG2 LMTK2 GRIN1 YWHAG YWHAH YWHAZ ZWINT FRMD4A MICU3 MACF1 CTNNA2 JPH3 NOS1AP | 6.20e-11 | 1139 | 251 | 32 | 36417873 | |
| Pubmed | RIPOR2 SETX KIAA0232 ITPRID2 KMT2C SETDB1 YWHAQ MGA FLNC CCDC186 LAMB1 RAPGEF1 YWHAB YWHAG YWHAH YWHAZ PPP4R3A ATF7IP MACF1 AKAP13 CTNNA1 | 7.79e-11 | 486 | 251 | 21 | 20936779 | |
| Pubmed | KIF21B GPRASP1 NCOA3 PDE4B HECW1 WDR81 RTN1 SYNGAP1 YWHAQ MGA SMG6 DMXL2 MIA3 ANK2 DSCAM GRIN1 YWHAB VIRMA YWHAG YWHAH YWHAZ GSN FRY PELP1 ATF7IP SAFB2 MACF1 CTNNA1 CTNNA2 | 1.06e-10 | 963 | 251 | 29 | 28671696 | |
| Pubmed | The interaction between casein kinase Ialpha and 14-3-3 is phosphorylation dependent. | 1.12e-10 | 6 | 251 | 5 | 19860830 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 LAMC3 DYSF BIRC6 REXO1 PCNX2 KMT2C FAT1 RIPOR1 SIPA1L2 CHPF BRAT1 DOCK6 SMG6 FLNC CRYBG2 TASP1 LMTK2 RAPGEF1 GTF2IRD1 RABL6 KLHL25 USP40 ANKRD11 AKAP13 ZFYVE26 HMGXB3 LRBA GGA1 HTT RAB11FIP3 | 1.31e-10 | 1105 | 251 | 31 | 35748872 |
| Pubmed | The cyclin-dependent kinase 11 interacts with 14-3-3 proteins. | 3.90e-10 | 7 | 251 | 5 | 15883043 | |
| Pubmed | 3.90e-10 | 7 | 251 | 5 | 31906564 | ||
| Pubmed | 3.90e-10 | 7 | 251 | 5 | 10620507 | ||
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 3.90e-10 | 7 | 251 | 5 | 36096339 | |
| Pubmed | 3.90e-10 | 7 | 251 | 5 | 27030597 | ||
| Pubmed | The expression of seven 14-3-3 isoforms in human meningioma. | 3.90e-10 | 7 | 251 | 5 | 20388496 | |
| Pubmed | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. | 3.90e-10 | 7 | 251 | 5 | 12383250 | |
| Pubmed | 3.90e-10 | 7 | 251 | 5 | 16868027 | ||
| Pubmed | 3.90e-10 | 7 | 251 | 5 | 21390248 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 KIAA0232 NAIP RTN3 TMPRSS5 DGKH ADGRV1 TASOR2 PCNX2 KMT2C RIPOR1 KATNIP DOCK6 MLPH CLEC16A UTRN ADGRD1 NOTCH3 SMG6 CACNB3 MIA3 MYRIP ARL15 GTF2IRD1 PPARGC1B LPP USP40 ANKRD11 STYXL1 MACF1 AKAP13 LRBA ZRANB1 SNX2 HTT | 8.71e-10 | 1489 | 251 | 35 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX KIAA0232 ITPRID2 ARHGEF17 FSIP2 STARD9 YWHAQ SIPA1L2 DOCK6 UTRN DOP1B ZCCHC8 LMTK2 EPB41L5 YWHAB VIRMA YWHAG YWHAH YWHAZ RGS12 LPP ANKRD11 MACF1 AKAP13 SNX2 NOS1AP | 9.84e-10 | 861 | 251 | 26 | 36931259 |
| Pubmed | 1.04e-09 | 8 | 251 | 5 | 15708996 | ||
| Pubmed | Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. | 1.04e-09 | 8 | 251 | 5 | 9524113 | |
| Pubmed | 1.04e-09 | 8 | 251 | 5 | 16045749 | ||
| Pubmed | 1.04e-09 | 8 | 251 | 5 | 18332103 | ||
| Pubmed | 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. | 1.04e-09 | 8 | 251 | 5 | 23622247 | |
| Pubmed | MON2 DCAF1 RIPOR2 TSPOAP1 KIAA0232 FSTL5 ARHGEF17 SETDB1 STARD9 RIPOR1 KATNIP SIPA1L2 CLEC16A DOP1B VIRMA ACIN1 MACF1 NOS1AP | 1.27e-09 | 407 | 251 | 18 | 12693553 | |
| Pubmed | 2.32e-09 | 9 | 251 | 5 | 18458160 | ||
| Pubmed | 2.32e-09 | 9 | 251 | 5 | 16581770 | ||
| Pubmed | MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 2.32e-09 | 9 | 251 | 5 | 16888623 | |
| Pubmed | 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). | 2.32e-09 | 9 | 251 | 5 | 12438239 | |
| Pubmed | Identification and characterization of the interaction between tuberin and 14-3-3zeta. | 2.32e-09 | 9 | 251 | 5 | 12176984 | |
| Pubmed | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. | 2.32e-09 | 9 | 251 | 5 | 16511560 | |
| Pubmed | 14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains. | 2.32e-09 | 9 | 251 | 5 | 34294877 | |
| Pubmed | 2.32e-09 | 9 | 251 | 5 | 12446771 | ||
| Pubmed | Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor. | 4.60e-09 | 10 | 251 | 5 | 14505491 | |
| Pubmed | 4.60e-09 | 10 | 251 | 5 | 12433946 | ||
| Pubmed | 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. | 4.60e-09 | 10 | 251 | 5 | 25154416 | |
| Pubmed | 4.60e-09 | 10 | 251 | 5 | 20478393 | ||
| Pubmed | Involvement of protein kinase PKN1 in G2/M delay caused by arsenite. | 4.60e-09 | 10 | 251 | 5 | 15791647 | |
| Pubmed | Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. | 4.60e-09 | 10 | 251 | 5 | 11697890 | |
| Pubmed | 8.39e-09 | 11 | 251 | 5 | 15696159 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 DCAF1 PASK EBNA1BP2 YWHAQ SIPA1L2 DHX29 UTRN NUP160 FLNC HYOU1 EPB41L5 LAMB1 RANBP6 YWHAB YWHAG YWHAH YWHAZ GSN PPP4R3A ARHGAP1 LPP STYXL1 CTNNA1 SNTB1 SNX2 | 1.24e-08 | 974 | 251 | 26 | 28675297 |
| Pubmed | Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. | 1.32e-08 | 5 | 251 | 4 | 19173300 | |
| Pubmed | Structural basis for protein-protein interactions in the 14-3-3 protein family. | 1.32e-08 | 5 | 251 | 4 | 17085597 | |
| Pubmed | 1.32e-08 | 5 | 251 | 4 | 23938468 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.32e-08 | 5 | 251 | 4 | 17855024 | |
| Pubmed | 1.43e-08 | 12 | 251 | 5 | 39406751 | ||
| Pubmed | 1.43e-08 | 12 | 251 | 5 | 18779327 | ||
| Pubmed | 1.43e-08 | 12 | 251 | 5 | 20642453 | ||
| Pubmed | Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. | 1.43e-08 | 12 | 251 | 5 | 19172738 | |
| Pubmed | 2.10e-08 | 25 | 251 | 6 | 21145499 | ||
| Pubmed | 2.31e-08 | 13 | 251 | 5 | 22222486 | ||
| Pubmed | 2.31e-08 | 13 | 251 | 5 | 19014373 | ||
| Pubmed | 2.31e-08 | 13 | 251 | 5 | 34654719 | ||
| Pubmed | EPHB6 MAGIX TASOR2 ATRIP CFAP70 YWHAQ MAGEC1 SIPA1L2 DOCK6 DHX29 LAMB1 YWHAB PPP4R3A USP40 MACF1 CAVIN1 CTNNA1 RBM34 | 2.71e-08 | 496 | 251 | 18 | 31343991 | |
| Pubmed | 3.57e-08 | 14 | 251 | 5 | 15265780 | ||
| Pubmed | 3.57e-08 | 14 | 251 | 5 | 16093354 | ||
| Pubmed | AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis. | 3.57e-08 | 14 | 251 | 5 | 36806887 | |
| Pubmed | SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. | 3.57e-08 | 14 | 251 | 5 | 33761321 | |
| Pubmed | 3.93e-08 | 6 | 251 | 4 | 16672277 | ||
| Pubmed | Uncoupling proteins 2 and 3 interact with members of the 14.3.3 family. | 3.93e-08 | 6 | 251 | 4 | 10785390 | |
| Pubmed | Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. | 3.93e-08 | 6 | 251 | 4 | 10713667 | |
| Pubmed | 3.93e-08 | 6 | 251 | 4 | 25588844 | ||
| Pubmed | PDE4B SYNGAP1 YWHAQ DMXL2 ANK2 GRIN1 YWHAB YWHAG YWHAH YWHAZ GSN MACF1 CTNNA2 | 4.25e-08 | 251 | 251 | 13 | 27507650 | |
| Pubmed | 4.39e-08 | 28 | 251 | 6 | 20012529 | ||
| Pubmed | RTN1 ADD3 PASK SIPA1L2 UTRN MIA3 LPP UNK MACF1 CAVIN1 SNX2 WIPI2 | 4.60e-08 | 209 | 251 | 12 | 36779422 | |
| Pubmed | 5.33e-08 | 15 | 251 | 5 | 23572552 | ||
| Pubmed | Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. | 5.33e-08 | 15 | 251 | 5 | 16041367 | |
| Pubmed | GGA2 SETX MYH13 MYO1C BIRC6 ADD3 TASOR2 FAT1 EBNA1BP2 MGA CLEC16A NUP160 RPGRIP1L DSCAM CCDC186 EPB41L5 ARL15 RABL6 ARHGAP1 ATF7IP LRBA GGA1 | 6.30e-08 | 777 | 251 | 22 | 35844135 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 BDP1 RAD18 SETX RTN3 ITPRID2 SETDB1 TONSL SIPA1L2 RPGRIP1L ZCCHC8 PPP4R3A ZWINT RIMBP3 NFATC2IP ATF7IP UNK MACF1 CDK11B | 6.87e-08 | 588 | 251 | 19 | 38580884 |
| Pubmed | 14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle. | 7.70e-08 | 16 | 251 | 5 | 23071090 | |
| Pubmed | Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. | 9.11e-08 | 7 | 251 | 4 | 15023544 | |
| Pubmed | 9.11e-08 | 7 | 251 | 4 | 22588126 | ||
| Pubmed | 9.11e-08 | 7 | 251 | 4 | 10441394 | ||
| Pubmed | Identification of five novel 14-3-3 isoforms interacting with the GPIb-IX complex in platelets. | 9.11e-08 | 7 | 251 | 4 | 19558434 | |
| Pubmed | 9.11e-08 | 7 | 251 | 4 | 15159416 | ||
| Pubmed | SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner. | 9.11e-08 | 7 | 251 | 4 | 19640509 | |
| Pubmed | HECW1 KIAA0232 ADGRV1 BIRC6 PASK KMT2C NRXN2 CLEC16A DOP1B SMG6 DMXL2 MACF1 | 1.03e-07 | 225 | 251 | 12 | 12168954 | |
| Pubmed | Interactome dynamics of RAF1-BRAF kinase monomers and dimers. | 1.08e-07 | 17 | 251 | 5 | 37045861 | |
| Pubmed | Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. | 1.49e-07 | 18 | 251 | 5 | 30240640 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | ITPKA SYNGAP1 AK5 DMXL2 CACNB3 ANK2 GRIN1 YWHAG YWHAH YWHAZ GSN MACF1 CTNNA2 | 1.58e-07 | 281 | 251 | 13 | 28706196 |
| Pubmed | Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. | 1.81e-07 | 8 | 251 | 4 | 23075850 | |
| Pubmed | 1.81e-07 | 8 | 251 | 4 | 8702721 | ||
| Pubmed | 2.01e-07 | 19 | 251 | 5 | 35343654 | ||
| Pubmed | MON2 MYO1C ATAD5 ITPRID2 BIRC6 YWHAQ UTRN ABCC1 MIA3 RPGRIP1L HYOU1 LMTK2 CDCA8 YWHAB YWHAG YWHAH YWHAZ PPP4R3A ARHGAP1 LPP INTS4 STYXL1 CTNNA1 SNTB1 NOS1AP | 2.07e-07 | 1049 | 251 | 25 | 27880917 | |
| Pubmed | EPHB6 GPRASP1 ERBB3 ADD3 SYNGAP1 UBE4A SETDB1 CHPF UTRN DOP1B DMXL2 ANK2 DSCAM ZCCHC8 MYRIP LAMB1 YWHAB YWHAG YWHAH YWHAZ ARHGAP1 FRY MTIF2 MACF1 ANKRD36 CTNNA1 LRBA JPH3 | 2.30e-07 | 1285 | 251 | 28 | 35914814 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 RAD18 MYO1C ITPRID2 REXO1 PASK MYO3A SAFB RIPOR1 DHX29 ZCCHC8 GTF2IRD1 VIRMA PPP4R3A SAFB2 ACIN1 UNK ELF1 CTNNA1 CDK11B SNX2 | 2.57e-07 | 774 | 251 | 21 | 15302935 |
| Pubmed | KIAA0232 TMOD2 ARHGEF17 SIPA1L2 DOCK6 FLNC YWHAB YWHAH CAVIN1 | 2.76e-07 | 122 | 251 | 9 | 30773093 | |
| Pubmed | Analysis of phosphorylation-dependent protein-protein interactions of histone h3. | 3.48e-07 | 21 | 251 | 5 | 25330109 | |
| Pubmed | Contribution of child ABC-transporter genetics to prenatal MeHg exposure and neurodevelopment. | 3.71e-07 | 3 | 251 | 3 | 35654246 | |
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 9778357 | ||
| Pubmed | The structural basis for 14-3-3:phosphopeptide binding specificity. | 3.71e-07 | 3 | 251 | 3 | 9428519 | |
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 17890284 | ||
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 8617504 | ||
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 25029804 | ||
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 23896815 | ||
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 30452683 | ||
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 24732756 | ||
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 8037685 | ||
| Pubmed | NCOA3 SETX BIRC6 TASOR2 KMT2C YWHAQ NUP160 CRYBG2 RPGRIP1L ZCCHC8 L1TD1 PELP1 INTS4 ACIN1 CTNNA1 CDK11B | 3.74e-07 | 469 | 251 | 16 | 27634302 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ITPRID2 ABCB1 DRG1 SAFB EBNA1BP2 YWHAQ MGA UTRN NUP160 FLNC HYOU1 CDCA8 YWHAB YWHAG YWHAH YWHAZ GSN TAF6L PELP1 SAFB2 ACIN1 MACF1 CTNNA1 SNX2 | 4.95e-07 | 1024 | 251 | 24 | 24711643 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYO1C WDR81 RTN3 SAFB TONSL ERP29 YWHAQ UTRN FLNC MIA3 HYOU1 YWHAB YWHAG YWHAH YWHAZ GSN ARHGAP1 MACF1 AKAP13 CTNNA1 LRBA | 5.05e-07 | 807 | 251 | 21 | 30575818 |
| Pubmed | 5.38e-07 | 10 | 251 | 4 | 12068294 | ||
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 5.69e-07 | 23 | 251 | 5 | 10708515 | |
| Interaction | ARHGEF28 interactions | 1.57e-09 | 42 | 245 | 9 | int:ARHGEF28 | |
| Interaction | DYRK1A interactions | BDP1 ERBB3 RAD18 MYO1C KIAA0232 TMOD2 ARHGEF17 TONSL YWHAQ SIPA1L2 DOCK6 CLEC16A UTRN FLNC DSCAM LAMB1 YWHAB VIRMA YWHAG YWHAH LPP SAFB2 CAVIN1 CTNNA1 LRBA NOS1AP | 4.11e-09 | 552 | 245 | 26 | int:DYRK1A |
| Interaction | SASH1 interactions | 8.13e-09 | 50 | 245 | 9 | int:SASH1 | |
| Interaction | SORBS2 interactions | MYO1C SYNGAP1 FAT1 YWHAQ YWHAB VIRMA YWHAG YWHAH YWHAZ AKAP13 CTNNA1 ZRANB1 | 1.08e-08 | 111 | 245 | 12 | int:SORBS2 |
| Interaction | KCNK15 interactions | 1.39e-08 | 8 | 245 | 5 | int:KCNK15 | |
| Interaction | FAM83G interactions | 1.95e-08 | 26 | 245 | 7 | int:FAM83G | |
| Interaction | SIPA1L3 interactions | RAD18 MYO1C YWHAQ SIPA1L2 RPGRIP1L YWHAB VIRMA YWHAG YWHAH YWHAZ CTNNA1 ZRANB1 | 2.18e-08 | 118 | 245 | 12 | int:SIPA1L3 |
| Interaction | KCNK9 interactions | 3.09e-08 | 9 | 245 | 5 | int:KCNK9 | |
| Interaction | USP31 interactions | 3.43e-08 | 28 | 245 | 7 | int:USP31 | |
| Interaction | DUSP16 interactions | KIAA0232 ITPRID2 TASOR2 FBXL18 NYNRIN YWHAQ SIPA1L2 RNF34 YWHAB VIRMA YWHAG YWHAH YWHAZ CEP164 ZWINT HTT | 3.63e-08 | 237 | 245 | 16 | int:DUSP16 |
| Interaction | SSH1 interactions | 4.05e-08 | 79 | 245 | 10 | int:SSH1 | |
| Interaction | FAM53B interactions | 4.99e-08 | 18 | 245 | 6 | int:FAM53B | |
| Interaction | OTOG interactions | 6.11e-08 | 10 | 245 | 5 | int:OTOG | |
| Interaction | RAPGEF2 interactions | BDP1 SYNGAP1 YWHAQ FLNC EPB41L5 YWHAB VIRMA YWHAG YWHAH YWHAZ HTT | 6.24e-08 | 105 | 245 | 11 | int:RAPGEF2 |
| Interaction | ALS2 interactions | 7.39e-08 | 31 | 245 | 7 | int:ALS2 | |
| Interaction | TNS3 interactions | 1.03e-07 | 87 | 245 | 10 | int:TNS3 | |
| Interaction | RALGAPA1 interactions | ERBB3 ARHGEF17 YWHAQ SIPA1L2 YWHAB VIRMA YWHAG YWHAH YWHAZ ZRANB1 | 1.03e-07 | 87 | 245 | 10 | int:RALGAPA1 |
| Interaction | ARL14EP interactions | 1.18e-07 | 33 | 245 | 7 | int:ARL14EP | |
| Interaction | ATG9A interactions | NCOA3 GGA2 TMEM74 RETREG3 RPS6KC1 ATRIP ABCD4 YWHAQ DMXL2 YWHAB YWHAG YWHAH YWHAZ RABL6 ARHGAP1 ATG3 LRBA GGA1 ZRANB1 SNX2 HTT | 1.34e-07 | 445 | 245 | 21 | int:ATG9A |
| Interaction | SPATA13 interactions | 1.41e-07 | 21 | 245 | 6 | int:SPATA13 | |
| Interaction | STOX2 interactions | 1.41e-07 | 21 | 245 | 6 | int:STOX2 | |
| Interaction | DENND1B interactions | 1.41e-07 | 21 | 245 | 6 | int:DENND1B | |
| Interaction | NHSL1 interactions | 1.47e-07 | 50 | 245 | 8 | int:NHSL1 | |
| Interaction | MIEF1 interactions | 1.73e-07 | 51 | 245 | 8 | int:MIEF1 | |
| Interaction | YWHAH interactions | KIF21B NCOA3 SETX KIAA0232 ITPRID2 ARHGEF17 PTH1R SYNGAP1 STARD9 YWHAQ SIPA1L2 DOCK6 CLEC16A UTRN DOP1B RPGRIP1L ZCCHC8 LMTK2 EPB41L5 YWHAB VIRMA YWHAG YWHAH YWHAZ RGS12 FRMD4A LPP ANKRD11 MACF1 AKAP13 LRBA ZRANB1 SNX2 HTT NOS1AP | 1.87e-07 | 1102 | 245 | 35 | int:YWHAH |
| Interaction | PPP1R3E interactions | 1.88e-07 | 12 | 245 | 5 | int:PPP1R3E | |
| Interaction | NDE1 interactions | TSPOAP1 YWHAQ UTRN YWHAB VIRMA YWHAG YWHAH YWHAZ USHBP1 GGA1 ZRANB1 | 1.91e-07 | 117 | 245 | 11 | int:NDE1 |
| Interaction | ATAT1 interactions | 1.92e-07 | 22 | 245 | 6 | int:ATAT1 | |
| Interaction | SIPA1L1 interactions | SYNGAP1 YWHAQ SIPA1L2 RPGRIP1L DSCAM YWHAB VIRMA YWHAG YWHAH YWHAZ CTNNA1 ZRANB1 HTT | 2.22e-07 | 174 | 245 | 13 | int:SIPA1L1 |
| Interaction | NUB1 interactions | 2.35e-07 | 53 | 245 | 8 | int:NUB1 | |
| Interaction | CCSER1 interactions | 2.58e-07 | 23 | 245 | 6 | int:CCSER1 | |
| Interaction | KCNK3 interactions | 3.03e-07 | 13 | 245 | 5 | int:KCNK3 | |
| Interaction | PANK3 interactions | 3.03e-07 | 13 | 245 | 5 | int:PANK3 | |
| Interaction | SYNRG interactions | 3.13e-07 | 75 | 245 | 9 | int:SYNRG | |
| Interaction | STARD9 interactions | 3.30e-07 | 38 | 245 | 7 | int:STARD9 | |
| Interaction | CCDC85C interactions | SETDB1 RPGRIP1L YWHAB VIRMA YWHAG YWHAH YWHAZ SYTL5 UNK CTNNA1 ZRANB1 | 3.75e-07 | 125 | 245 | 11 | int:CCDC85C |
| Interaction | PLEKHG3 interactions | 3.90e-07 | 100 | 245 | 10 | int:PLEKHG3 | |
| Interaction | TMCC3 interactions | 3.98e-07 | 39 | 245 | 7 | int:TMCC3 | |
| Interaction | TMCC1 interactions | 4.43e-07 | 25 | 245 | 6 | int:TMCC1 | |
| Interaction | FAM117B interactions | 4.77e-07 | 40 | 245 | 7 | int:FAM117B | |
| Interaction | KANK1 interactions | 4.77e-07 | 40 | 245 | 7 | int:KANK1 | |
| Interaction | FRYL interactions | 4.83e-07 | 58 | 245 | 8 | int:FRYL | |
| Interaction | ARHGEF17 interactions | 4.83e-07 | 58 | 245 | 8 | int:ARHGEF17 | |
| Interaction | PPP1R12C interactions | 4.83e-07 | 58 | 245 | 8 | int:PPP1R12C | |
| Interaction | MORC3 interactions | 5.48e-07 | 80 | 245 | 9 | int:MORC3 | |
| Interaction | SIPA1 interactions | 5.69e-07 | 41 | 245 | 7 | int:SIPA1 | |
| Interaction | PLEKHM3 interactions | 5.70e-07 | 26 | 245 | 6 | int:PLEKHM3 | |
| Interaction | PI4KB interactions | 6.31e-07 | 60 | 245 | 8 | int:PI4KB | |
| Interaction | SYDE2 interactions | 7.99e-07 | 43 | 245 | 7 | int:SYDE2 | |
| Interaction | NAV2 interactions | 7.99e-07 | 43 | 245 | 7 | int:NAV2 | |
| Interaction | EPB41L2 interactions | DCAF1 RAD18 SYNGAP1 YWHAQ ARL15 YWHAB YWHAG YWHAH YWHAZ RABL6 ARHGAP1 ACIN1 CAVIN1 CTNNA1 ZRANB1 HTT | 8.55e-07 | 299 | 245 | 16 | int:EPB41L2 |
| Interaction | CARMIL2 interactions | 9.14e-07 | 28 | 245 | 6 | int:CARMIL2 | |
| Interaction | WWC2 interactions | 9.14e-07 | 28 | 245 | 6 | int:WWC2 | |
| Interaction | ARHGEF5 interactions | 9.23e-07 | 85 | 245 | 9 | int:ARHGEF5 | |
| Interaction | IQSEC2 interactions | 9.41e-07 | 44 | 245 | 7 | int:IQSEC2 | |
| Interaction | C2CD4B interactions | 9.41e-07 | 44 | 245 | 7 | int:C2CD4B | |
| Interaction | SAMSN1 interactions | 9.98e-07 | 16 | 245 | 5 | int:SAMSN1 | |
| Interaction | TESPA1 interactions | 9.98e-07 | 16 | 245 | 5 | int:TESPA1 | |
| Interaction | RGS12 interactions | 1.10e-06 | 45 | 245 | 7 | int:RGS12 | |
| Interaction | RAB11A interactions | MON2 RTN3 BIRC6 ADD3 ABCB1 CLEC16A DOP1B ABCC1 DMXL2 HYOU1 LMTK2 EPB41L5 RANBP6 VIRMA YWHAG GSN RABL6 ARHGAP1 ATG3 SYTL5 CAVIN1 LRBA ZRANB1 SNX2 WIPI2 RBM34 HTT RAB11FIP3 | 1.11e-06 | 830 | 245 | 28 | int:RAB11A |
| Interaction | VCL interactions | MYO1C BIRC6 PASK YWHAQ SIPA1L2 EPB41L5 VIRMA YWHAG YWHAH YWHAZ GSN LPP UNK MACF1 CTNNA1 ZRANB1 | 1.11e-06 | 305 | 245 | 16 | int:VCL |
| Interaction | GSK3A interactions | RTN1 ADD3 PASK EBNA1BP2 YWHAQ SIPA1L2 UTRN MIA3 SRBD1 YWHAB YWHAG YWHAH LPP ACIN1 UNK MACF1 CAVIN1 CTNNA1 SNX2 WIPI2 | 1.11e-06 | 464 | 245 | 20 | int:GSK3A |
| Interaction | PHACTR2 interactions | 1.14e-06 | 29 | 245 | 6 | int:PHACTR2 | |
| Interaction | FAM13A interactions | 1.14e-06 | 29 | 245 | 6 | int:FAM13A | |
| Interaction | PARD3B interactions | 1.29e-06 | 46 | 245 | 7 | int:PARD3B | |
| Interaction | ZNF395 interactions | 1.40e-06 | 17 | 245 | 5 | int:ZNF395 | |
| Interaction | ARAP2 interactions | 1.41e-06 | 30 | 245 | 6 | int:ARAP2 | |
| Interaction | TICRR interactions | 1.41e-06 | 30 | 245 | 6 | int:TICRR | |
| Interaction | RASSF2 interactions | 1.50e-06 | 47 | 245 | 7 | int:RASSF2 | |
| Interaction | AKAP13 interactions | SYNGAP1 YWHAQ YWHAB VIRMA YWHAG YWHAH YWHAZ AKAP13 ZRANB1 RAPGEFL1 | 1.55e-06 | 116 | 245 | 10 | int:AKAP13 |
| Interaction | MAP3K9 interactions | 1.73e-06 | 31 | 245 | 6 | int:MAP3K9 | |
| Interaction | MTMR12 interactions | 1.73e-06 | 48 | 245 | 7 | int:MTMR12 | |
| Interaction | NHS interactions | 1.73e-06 | 48 | 245 | 7 | int:NHS | |
| Interaction | MYCBP2 interactions | KIF21B ERBB3 SYNGAP1 CSRNP1 YWHAQ CLEC16A ANK2 YWHAB VIRMA YWHAG YWHAH YWHAZ RGS12 GSN PELP1 MACF1 ZRANB1 | 1.78e-06 | 355 | 245 | 17 | int:MYCBP2 |
| Interaction | SRGAP1 interactions | 1.81e-06 | 92 | 245 | 9 | int:SRGAP1 | |
| Interaction | OBSL1 interactions | EPHB6 TMEM74 TASOR2 PASK SAFB ATRIP EBNA1BP2 CFAP70 YWHAQ SIPA1L2 MGA DHX29 CLEC16A UTRN NUP160 FLNC LAMB1 CDCA8 YWHAZ GSN PPP4R3A PELP1 ATG3 SAFB2 ACIN1 MACF1 CAVIN1 CTNNA1 RBM34 | 1.83e-06 | 902 | 245 | 29 | int:OBSL1 |
| Interaction | CEP112 interactions | 2.11e-06 | 32 | 245 | 6 | int:CEP112 | |
| Interaction | PLEKHA2 interactions | 2.17e-06 | 94 | 245 | 9 | int:PLEKHA2 | |
| Interaction | NFATC3 interactions | 2.30e-06 | 50 | 245 | 7 | int:NFATC3 | |
| Interaction | CCDC88C interactions | 2.34e-06 | 71 | 245 | 8 | int:CCDC88C | |
| Interaction | CEP85L interactions | 2.55e-06 | 33 | 245 | 6 | int:CEP85L | |
| Interaction | FAM163A interactions | 2.58e-06 | 19 | 245 | 5 | int:FAM163A | |
| Interaction | TRAPPC11 interactions | 2.59e-06 | 96 | 245 | 9 | int:TRAPPC11 | |
| Interaction | RABEP1 interactions | GGA2 TMEM74 TMEM266 YWHAQ RPGRIP1L CCDC186 YWHAB YWHAG YWHAH YWHAZ GGA1 ZRANB1 | 2.74e-06 | 184 | 245 | 12 | int:RABEP1 |
| Interaction | REEP3 interactions | 3.07e-06 | 34 | 245 | 6 | int:REEP3 | |
| Interaction | MARK1 interactions | 3.21e-06 | 74 | 245 | 8 | int:MARK1 | |
| Interaction | EPB41L1 interactions | SYNGAP1 YWHAQ YWHAB VIRMA YWHAG YWHAH YWHAZ DNAAF2 ARHGAP1 USP40 ACIN1 NOS1AP | 3.25e-06 | 187 | 245 | 12 | int:EPB41L1 |
| Interaction | PARP8 interactions | 3.40e-06 | 20 | 245 | 5 | int:PARP8 | |
| Interaction | MLXIP interactions | 3.40e-06 | 20 | 245 | 5 | int:MLXIP | |
| Interaction | FRMD6 interactions | 3.45e-06 | 53 | 245 | 7 | int:FRMD6 | |
| Interaction | LYST interactions | 3.45e-06 | 53 | 245 | 7 | int:LYST | |
| Interaction | ARHGAP21 interactions | MYO1C SYNGAP1 YWHAQ CLEC16A YWHAB VIRMA YWHAG YWHAH YWHAZ AKAP13 CAVIN1 CTNNA1 ZRANB1 | 3.66e-06 | 223 | 245 | 13 | int:ARHGAP21 |
| Interaction | COBLL1 interactions | 3.94e-06 | 76 | 245 | 8 | int:COBLL1 | |
| Interaction | SPIRE2 interactions | 4.42e-06 | 21 | 245 | 5 | int:SPIRE2 | |
| Interaction | PITPNC1 interactions | 4.42e-06 | 21 | 245 | 5 | int:PITPNC1 | |
| Interaction | RFX7 interactions | 4.42e-06 | 21 | 245 | 5 | int:RFX7 | |
| Interaction | KIF21B interactions | 4.45e-06 | 55 | 245 | 7 | int:KIF21B | |
| Interaction | MINK1 interactions | DCAF1 SYNGAP1 EBNA1BP2 YWHAQ RAPGEF1 ARL15 YWHAB YWHAG YWHAH YWHAZ CAVIN1 HTT | 4.50e-06 | 193 | 245 | 12 | int:MINK1 |
| Interaction | PPP4R4 interactions | 5.67e-06 | 22 | 245 | 5 | int:PPP4R4 | |
| Interaction | PPP1R3D interactions | 5.67e-06 | 22 | 245 | 5 | int:PPP1R3D | |
| Cytoband | 5q32 | 2.23e-04 | 54 | 251 | 4 | 5q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q23 | 2.25e-04 | 220 | 251 | 7 | chr11q23 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 1.48e-09 | 7 | 171 | 5 | 1053 | |
| GeneFamily | ATP binding cassette subfamily B | 2.42e-06 | 11 | 171 | 4 | 806 | |
| GeneFamily | Golgi associated, gamma adaptin ear containing, ARF binding proteins | 2.65e-04 | 3 | 171 | 2 | 1031 | |
| GeneFamily | Myosin heavy chains | 3.48e-04 | 15 | 171 | 3 | 1098 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 5.27e-04 | 4 | 171 | 2 | 1244 | |
| GeneFamily | WD repeat domain containing|ERCC excision repair associated | 1.81e-03 | 7 | 171 | 2 | 1268 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | KIF21B RIPOR2 DYSF REXO1 SETDB1 RIPOR1 KATNIP BRAT1 CLEC16A UTRN DOP1B DAGLB RAPGEF1 E4F1 TAF6L ARHGAP1 NFATC2IP CHFR ANKRD11 SAFB2 INTS4 UNK AKAP13 WDR73 ZFYVE26 ANKRD36 CDK11B | 1.69e-07 | 905 | 249 | 27 | M40865 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KIF21B BDP1 GPRASP1 RIPOR2 PSD TSPOAP1 TMOD2 CHGA RTN1 FSIP2 PPARGC1A NRXN2 CSRNP3 ADGRD1 DOP1B CACNB3 MIA3 ANK2 RETREG2 DSCAM CCDC186 YWHAG PPARGC1B FRY MICU3 ANKRD36 CTNNA2 JPH3 | 2.55e-06 | 1106 | 249 | 28 | M39071 |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN | SETX RETREG3 KCNS1 BRAT1 MGA DMXL2 CRYBG2 RAPGEF1 SRBD1 RGS12 NFATC2IP | 3.32e-06 | 198 | 249 | 11 | M6033 |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 4.15e-06 | 26 | 249 | 5 | M1380 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | KIF21B BDP1 GPRASP1 RIPOR2 PSD TMOD2 CHGA RTN1 PPARGC1A NRXN2 CSRNP3 AK5 ANK2 DSCAM MYRIP FRMD4A PPARGC1B FRY MICU3 JPH3 | 1.45e-05 | 703 | 249 | 20 | M39070 |
| Coexpression | PRC2_EED_DN.V1_DN | TNFRSF10D ARHGEF17 NYNRIN KCNS1 UTRN CRYBG2 RAPGEF1 CDCA8 MICALL2 ABCB8 | 1.71e-05 | 193 | 249 | 10 | M2734 |
| Coexpression | GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN | KIF21B TSPOAP1 PASK MAGEC1 MIA3 HYOU1 E4F1 FRY ARHGAP45 RBM34 | 2.04e-05 | 197 | 249 | 10 | M5475 |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_DC_UP | PSD RETREG3 USH2A CLEC16A NUP160 DOP1B FAM131A GRIN1 YWHAH FUCA1 | 2.22e-05 | 199 | 249 | 10 | M5145 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | KIF21B RIPOR2 TSPOAP1 TMOD2 CHGA RTN1 NRXN2 CSRNP3 USH2A CACNB3 ANK2 DSCAM YWHAG FRY MICU3 | 4.31e-05 | 465 | 249 | 15 | M39066 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | HECW1 ADGRV1 PTH1R EBNA1BP2 ABCC2 SMG6 MYRIP GTF2IRD1 FRMD4A ANKRD11 SAFB2 ACIN1 AKAP13 RAB11FIP3 | 5.06e-05 | 417 | 249 | 14 | M39224 |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 6.21e-05 | 181 | 249 | 9 | M8662 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 6.75e-05 | 183 | 249 | 9 | M8189 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | SETX PSD TSPOAP1 CHGA RPS6KC1 NRXN2 CACNB3 YWHAG CEP164 RABL6 TAF6L NFATC2IP ANKRD36 | 9.83e-05 | 389 | 249 | 13 | M39102 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | KIF21B GPRASP1 RIPOR2 PSD FSTL4 TMOD2 CHGA RTN1 NRXN2 CSRNP3 ANK2 DSCAM MYRIP YWHAG CTNNA2 | 1.11e-04 | 506 | 249 | 15 | M39067 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | GPRASP1 RIPOR2 PSD TMOD2 CHGA RTN1 NRXN2 CSRNP3 AK5 ANK2 YWHAG YWHAH FRY JPH3 | 1.13e-04 | 450 | 249 | 14 | M39072 |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN | 1.19e-04 | 197 | 249 | 9 | M5853 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 1.28e-04 | 199 | 249 | 9 | M5620 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | KIF21B RIPOR2 REXO1 KATNIP DAGLB DMXL2 E4F1 TAF6L ARHGAP1 NFATC2IP ANKRD11 SAFB2 UNK AKAP13 WDR73 ANKRD36 CDK11B | 1.31e-04 | 634 | 249 | 17 | M40866 |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 1.33e-04 | 200 | 249 | 9 | M5980 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 1.33e-04 | 200 | 249 | 9 | M8030 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN | 1.33e-04 | 200 | 249 | 9 | M8486 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | MON2 PDE4B CSRNP1 CLEC16A ZCCHC8 E4F1 NFATC2IP AKAP13 ARHGAP45 | 1.33e-04 | 200 | 249 | 9 | M6096 |
| Coexpression | GSE3982_BCELL_VS_BASOPHIL_DN | 1.33e-04 | 200 | 249 | 9 | M5540 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP | 1.33e-04 | 200 | 249 | 9 | M5787 | |
| Coexpression | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN | GGA2 SETX DYSF TLR8 ADD3 RIPOR1 DMXL2 TGFBI FRMD4A CHFR ZFYVE26 FUCA1 ARHGAP45 SNX2 | 1.36e-04 | 458 | 249 | 14 | M4785 |
| Coexpression | GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP | 1.46e-04 | 159 | 249 | 8 | M8814 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP | 1.60e-04 | 161 | 249 | 8 | M9446 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | KIF21B GPRASP1 PSD TSPOAP1 TMOD2 CHGA RTN1 NRXN2 CSRNP3 ANK2 DSCAM MYRIP YWHAG FRY CTNNA2 JPH3 | 1.62e-04 | 584 | 249 | 16 | M39068 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | MON2 DGKH BIRC6 TASOR2 KMT2C UTRN SMG6 ATF7IP LPP ANKRD11 MACF1 ANKRD36 LRBA | 6.02e-11 | 188 | 251 | 13 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | LAMC3 DGKH ARHGEF17 PTH1R FAT1 STARD9 DOCK6 ADGRD1 NOTCH3 COL6A3 LAMB1 LPP | 9.42e-10 | 190 | 251 | 12 | 4eb92aef1ee868f4537483d19014d947b7684612 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | LAMC3 DGKH ARHGEF17 PTH1R FAT1 STARD9 DOCK6 ADGRD1 NOTCH3 COL6A3 LAMB1 LPP | 9.42e-10 | 190 | 251 | 12 | 7be4341e2909101d756f14031c21e705eb45e69a |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LAMC3 DGKH ARHGEF17 PTH1R FAT1 STARD9 DOCK6 UTRN ADGRD1 NOTCH3 LAMB1 | 9.47e-09 | 186 | 251 | 11 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | LAMC3 DGKH ARHGEF17 PTH1R MYO3A STARD9 DOCK6 ADGRD1 NOTCH3 COL6A3 LAMB1 | 1.12e-08 | 189 | 251 | 11 | d7ed96add29f219183c802895fbff519b627f635 |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | RIPOR2 SETX RETREG3 RIPOR1 RETREG2 CCDC186 VIRMA PPP4R3A MACF1 ARHGAP45 | 1.97e-08 | 155 | 251 | 10 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | GPRASP1 HECW1 RTN1 PCNX2 GRIN1 YWHAB YWHAG YWHAZ ZWINT MICU3 JPH3 | 2.01e-08 | 200 | 251 | 11 | c888fd487990cad482a4ca47601cdebc0ca3f3ce |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | DCAF1 SYNGAP1 PCNX2 KATNIP CFAP70 MGA IMPG2 MIA3 ATF7IP USP40 | 3.79e-08 | 166 | 251 | 10 | 32d2eaf8a5d03881bf74d680825af2d5110b082d |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | RIPOR2 SETX RETREG3 RIPOR1 RETREG2 CCDC186 VIRMA PPP4R3A MACF1 ARHGAP45 | 5.01e-08 | 171 | 251 | 10 | d18855b24aadea38fd1e4592f945cf15b85e05f1 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LAMC3 DGKH ARHGEF17 MYO3A FAT1 STARD9 ADGRD1 NOTCH3 COL6A3 LAMB1 | 1.16e-07 | 187 | 251 | 10 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LAMC3 DGKH ARHGEF17 MYO3A STARD9 DOCK6 ADGRD1 NOTCH3 COL6A3 LAMB1 | 1.16e-07 | 187 | 251 | 10 | a2bf958ea59c359a265bfa437d59315e1920cdd4 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TSPOAP1 FSTL4 RTN1 ITPKA PCNX2 NRXN2 CACNB3 GRIN1 NOS1AP RAPGEFL1 | 1.56e-07 | 193 | 251 | 10 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TSPOAP1 FSTL4 RTN1 ITPKA PCNX2 NRXN2 CACNB3 GRIN1 NOS1AP RAPGEFL1 | 1.56e-07 | 193 | 251 | 10 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TSPOAP1 FSTL4 RTN1 ITPKA PCNX2 NRXN2 CACNB3 GRIN1 NOS1AP RAPGEFL1 | 1.56e-07 | 193 | 251 | 10 | 0c652ebe22ce5d2927599dd97ef1920547858395 |
| ToppCell | primary_visual_cortex-Neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | GPRASP1 CHGA RTN1 ZCCHC18 GRIN1 YWHAB YWHAG YWHAH YWHAZ ZWINT | 1.80e-07 | 196 | 251 | 10 | 8efc2b3a95f57c31be203ac781b2098d4909297f |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 2.07e-07 | 199 | 251 | 10 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 2.07e-07 | 199 | 251 | 10 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | LAMC3 DGKH ARHGEF17 PTH1R FAT1 STARD9 DOCK6 ADGRD1 NOTCH3 LAMB1 | 2.17e-07 | 200 | 251 | 10 | 0c648941447c738caf62f2d71e296d6cca492c8b |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | LAMC3 DGKH ARHGEF17 PTH1R FAT1 STARD9 DOCK6 ADGRD1 NOTCH3 LAMB1 | 2.17e-07 | 200 | 251 | 10 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BDP1 SETX BIRC6 KMT2C UTRN ATF7IP ANKRD11 ACIN1 MACF1 AKAP13 | 2.17e-07 | 200 | 251 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | LAMC3 DGKH ARHGEF17 PTH1R FAT1 STARD9 DOCK6 ADGRD1 NOTCH3 LAMB1 | 2.17e-07 | 200 | 251 | 10 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.17e-07 | 200 | 251 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | RIPOR2 TSPOAP1 RETREG3 CCDC186 VIRMA PPP4R3A MACF1 LGR6 ARHGAP45 | 7.68e-07 | 177 | 251 | 9 | 6978a22fef40c8b455342373abe7593f5ede0fa4 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | RIPOR2 TSPOAP1 RETREG3 CCDC186 VIRMA PPP4R3A MACF1 LGR6 ARHGAP45 | 7.68e-07 | 177 | 251 | 9 | 936ab2b180a052387124f68d0c7f41c0b164e748 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | RIPOR2 TSPOAP1 RETREG3 CCDC186 VIRMA PPP4R3A MACF1 LGR6 ARHGAP45 | 7.68e-07 | 177 | 251 | 9 | d5aeda113afaa2425874394610344570c9078478 |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-07 | 180 | 251 | 9 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-07 | 180 | 251 | 9 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-06 | 183 | 251 | 9 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | RIPOR2 TSPOAP1 RETREG3 RETREG2 CCDC186 VIRMA PPP4R3A MACF1 ARHGAP45 | 1.01e-06 | 183 | 251 | 9 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SYT17 LAMC3 ARHGEF17 FAT1 PLEKHH2 NOTCH3 COL6A3 LAMB1 FRMD4A | 1.06e-06 | 184 | 251 | 9 | 102b6f621a5b551e622f97b12d787c080b052a72 |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 185 | 251 | 9 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 185 | 251 | 9 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 185 | 251 | 9 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | EPHB6 ERBB3 TSPOAP1 PPARGC1A ABCC2 PLEKHH2 ADGRD1 FLNC STYXL1 | 1.16e-06 | 186 | 251 | 9 | 6259f0f2d5bc863782d09a901d6be2f387d1f074 |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | LAMC3 ARHGEF17 PTH1R STARD9 DOCK6 ADGRD1 NOTCH3 COL6A3 LAMB1 | 1.21e-06 | 187 | 251 | 9 | 62759efb660179402fb574ce5701c89a2e17bcfe |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-06 | 188 | 251 | 9 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LAMC3 ARHGEF17 PTH1R STARD9 TMEM266 DOCK6 ADGRD1 NOTCH3 LAMB1 | 1.45e-06 | 191 | 251 | 9 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 191 | 251 | 9 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.45e-06 | 191 | 251 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LAMC3 ARHGEF17 PTH1R STARD9 TMEM266 DOCK6 ADGRD1 NOTCH3 LAMB1 | 1.45e-06 | 191 | 251 | 9 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-06 | 193 | 251 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.58e-06 | 193 | 251 | 9 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 194 | 251 | 9 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 194 | 251 | 9 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 194 | 251 | 9 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.72e-06 | 195 | 251 | 9 | bff7685784688425bebd78b0f284a6d4475a9415 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-06 | 197 | 251 | 9 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.87e-06 | 197 | 251 | 9 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-06 | 197 | 251 | 9 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | ASK440|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.95e-06 | 198 | 251 | 9 | f3ed6efd521c691debae32a803972bed5d069332 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.95e-06 | 198 | 251 | 9 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-06 | 199 | 251 | 9 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 2.03e-06 | 199 | 251 | 9 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.03e-06 | 199 | 251 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 2.03e-06 | 199 | 251 | 9 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-06 | 199 | 251 | 9 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.03e-06 | 199 | 251 | 9 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.11e-06 | 200 | 251 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.11e-06 | 200 | 251 | 9 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.11e-06 | 200 | 251 | 9 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.11e-06 | 200 | 251 | 9 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.11e-06 | 200 | 251 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.17e-06 | 168 | 251 | 8 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-06 | 169 | 251 | 8 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-06 | 170 | 251 | 8 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 5.89e-06 | 171 | 251 | 8 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-06 | 175 | 251 | 8 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.59e-06 | 177 | 251 | 8 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.59e-06 | 177 | 251 | 8 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.91e-06 | 178 | 251 | 8 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 180 | 251 | 8 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 8.58e-06 | 180 | 251 | 8 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.94e-06 | 181 | 251 | 8 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 184 | 251 | 8 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 184 | 251 | 8 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-05 | 185 | 251 | 8 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 186 | 251 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 187 | 251 | 8 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 187 | 251 | 8 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 187 | 251 | 8 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-05 | 188 | 251 | 8 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-05 | 189 | 251 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.22e-05 | 189 | 251 | 8 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.27e-05 | 190 | 251 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.27e-05 | 190 | 251 | 8 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.32e-05 | 191 | 251 | 8 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 192 | 251 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-05 | 194 | 251 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.48e-05 | 194 | 251 | 8 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 194 | 251 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 194 | 251 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 194 | 251 | 8 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 194 | 251 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 1.53e-05 | 195 | 251 | 8 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.53e-05 | 195 | 251 | 8 | aed243418cdb5df4563a7b935c1ecbd744590901 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 196 | 251 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-05 | 196 | 251 | 8 | e874aa82a20bb59582c8cd7f8d30b2ed02903a85 | |
| ToppCell | frontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.59e-05 | 196 | 251 | 8 | de7d10da862f98894ce47244fbc992f4a12d63bb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 196 | 251 | 8 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-05 | 196 | 251 | 8 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.49e-05 | 49 | 149 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | calcein AM | 9.44e-07 | 8 | 249 | 4 | ctd:C085925 | |
| Drug | nicotine glucuronide | 9.44e-07 | 8 | 249 | 4 | CID003035848 | |
| Drug | T beta-MC | 9.44e-07 | 8 | 249 | 4 | CID000168408 | |
| Drug | Technetium Tc 99m Sestamibi | 1.29e-06 | 3 | 249 | 3 | ctd:D017256 | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | SYT17 FBXL5 FBXL18 KCNS1 RIPOR1 KATNIP EPB41L5 TEX15 RGS12 TAF6L AKAP13 RAB11FIP3 | 1.38e-06 | 191 | 249 | 12 | 7417_UP |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | ARHGEF17 FBXL18 RIPOR1 NOTCH3 CACNB3 CEP164 RGS12 FRMD4A LPP SAFB2 CAVIN1 RAB11FIP3 | 1.63e-06 | 194 | 249 | 12 | 5362_UP |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | DCAF1 GGA2 ITPKA PASK RIPOR1 NUP160 SH3TC2 C9orf40 ARL15 RGS12 TAF6L RBM34 | 2.01e-06 | 198 | 249 | 12 | 7383_UP |
| Drug | Soybean Oil | 2.04e-06 | 20 | 249 | 5 | ctd:D013024 | |
| Drug | Benzbromarone [3562-84-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | HECW1 ARHGEF17 PTH1R AK5 ZSCAN2 LMTK2 GSN MICALL2 SNTB1 INPP5J JPH3 RAPGEFL1 | 2.12e-06 | 199 | 249 | 12 | 6669_UP |
| Drug | estradiol-17 beta-glucuronide | 3.40e-06 | 22 | 249 | 5 | ctd:C025483 | |
| Drug | fluorexon | 5.13e-06 | 4 | 249 | 3 | ctd:C007740 | |
| Drug | NSC648766 | 8.36e-06 | 93 | 249 | 8 | CID000003199 | |
| Drug | procymidone | ERBB3 CHGA ABCB4 SYNGAP1 NRXN2 NOTCH3 CACNB3 HYOU1 GRIN1 HTT | 8.37e-06 | 155 | 249 | 10 | ctd:C035988 |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | GGA2 SETDB1 SAFB NOTCH3 SMG6 CACNB3 PPP4R3A TGFBI SAFB2 GGA1 SNTB1 | 9.22e-06 | 192 | 249 | 11 | 4449_DN |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A | HECW1 FSTL4 PTH1R MYO3A NRXN2 NOTCH3 IMPG2 SMG6 ANK2 CAVIN1 WIPI2 | 1.23e-05 | 198 | 249 | 11 | 3059_UP |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | TRADD KIAA0232 ITPKA NYNRIN DSCAM ARHGAP1 KLHL25 MYH15 AKAP13 ARHGAP45 GGA1 | 1.23e-05 | 198 | 249 | 11 | 7549_UP |
| Drug | robinetin | 1.28e-05 | 14 | 249 | 4 | CID005281692 | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; HL60; HG-U133A | NCOA3 PDE4B ERCC6 ABCD4 FLNC DSCAM SRBD1 RGS12 FRY MICALL2 GGA1 | 1.29e-05 | 199 | 249 | 11 | 2028_UP |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | TNFRSF10D ITPKA ABCB4 PCNX2 FBXL18 CHPF DOCK6 CLEC16A TIGD6 RBM34 RAB11FIP3 | 1.35e-05 | 200 | 249 | 11 | 2148_UP |
| Drug | Loratadine | 1.71e-05 | 30 | 249 | 5 | ctd:D017336 | |
| Drug | bisbenzimide ethoxide trihydrochloride | 2.52e-05 | 6 | 249 | 3 | ctd:C017807 | |
| Drug | Cefpiramide acid | 2.52e-05 | 6 | 249 | 3 | CID000002642 | |
| Drug | v 104 | 2.52e-05 | 6 | 249 | 3 | CID000107262 | |
| Drug | 2-acetylaminofluorene | ABCB1 ABCB4 PPARGC1A TONSL ABCC2 TASP1 RNF34 ABCB11 ACIN1 IL1A HTT JPH3 | 3.42e-05 | 262 | 249 | 12 | CID000005897 |
| Drug | trequinsin | 4.05e-05 | 58 | 249 | 6 | CID000005537 | |
| Drug | AC1O3GBZ | 4.29e-05 | 36 | 249 | 5 | CID006327751 | |
| Drug | vadimezan | 4.38e-05 | 7 | 249 | 3 | ctd:C066668 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | GGA2 ATAD5 PCNX2 FBXL18 RIPOR1 NOTCH3 ARHGAP1 MICALL2 LPP RAB11FIP3 | 4.65e-05 | 189 | 249 | 10 | 5203_DN |
| Drug | taxol | ERBB3 PDE4B NAIP LAMC3 TNFRSF10D BIRC6 ABCB1 ABCB4 TONSL ABCC2 ABCC1 LAMB1 TGFBI CHFR ABCB11 IL1A HTT JPH3 | 4.89e-05 | 560 | 249 | 18 | CID000004666 |
| Drug | benzbromarone | 4.92e-05 | 37 | 249 | 5 | CID000002333 | |
| Drug | N-acetoxy-2-acetylaminofluorene | 4.92e-05 | 37 | 249 | 5 | CID000022469 | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | MON2 ATAD5 UTRN CCDC186 EPB41L5 FAM131A RGS12 ARHGAP1 CAVIN1 RBM34 | 5.31e-05 | 192 | 249 | 10 | 4746_DN |
| Drug | Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A | DYSF PASK SAFB C9orf40 LAMB1 PPP4R3A TAF6L MICALL2 ATG3 AKAP13 | 6.05e-05 | 195 | 249 | 10 | 7432_DN |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A | GGA2 ITPKA PCNX2 FBXL18 NUP160 DOP1B SMG6 CACNB3 CATSPER2 MRNIP | 6.05e-05 | 195 | 249 | 10 | 7372_UP |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 6.31e-05 | 196 | 249 | 10 | 4722_UP | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 6.31e-05 | 196 | 249 | 10 | 4321_UP | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; PC3; HT_HG-U133A | MORC1 KIF21B PDE4B TMPRSS5 DOCK6 CRYBG2 DSCAM RGS12 FRMD4A SAFB2 | 6.31e-05 | 196 | 249 | 10 | 4564_UP |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | NCOA3 PASK KCNS1 RIPOR1 CRYBG2 CCDC186 CEP164 TAF6L FRMD4A INPP5J | 6.31e-05 | 196 | 249 | 10 | 3783_DN |
| Drug | Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; MCF7; HT_HG-U133A | ARHGEF17 NOTCH3 MIA3 RPGRIP1L EPB41L5 LAMB1 DESI2 CEP164 PPP4R3A RAB11FIP3 | 6.59e-05 | 197 | 249 | 10 | 5437_DN |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | KIF21B HECW1 PASK MAGEC1 MTRF1L SMG6 FAM131A KLHL25 CATSPER2 NOS1AP | 6.59e-05 | 197 | 249 | 10 | 5483_UP |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | MYO1C PASK NOTCH3 ABCC1 EPB41L5 DGKD GTF2IRD1 MRNIP AKAP13 ZFYVE26 | 6.59e-05 | 197 | 249 | 10 | 3415_DN |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A | MON2 TRADD TLR8 ABCB4 RIPOR1 CLEC16A GSN CATSPER2 MICALL2 HMGXB3 | 6.59e-05 | 197 | 249 | 10 | 2975_DN |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | GGA2 DYSF ABCC2 NOTCH3 IMPG2 CRYBG2 TEX15 RGS12 CAVIN1 SNTB1 | 6.59e-05 | 197 | 249 | 10 | 3525_UP |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A | ITPRID2 PASK RIPOR1 NUP160 ABCC1 DSCAM ARL15 YWHAZ MACF1 RAPGEFL1 | 6.59e-05 | 197 | 249 | 10 | 2768_DN |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; HL60; HG-U133A | MYO1C SAFB FBXL18 UTRN MICALL2 ANKRD11 MACF1 AKAP13 CTNNA1 SNTB1 | 6.87e-05 | 198 | 249 | 10 | 1588_UP |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | HECW1 SYT17 PASK KCNS1 TAF6L KLHL25 SAFB2 GGA1 WIPI2 RAB11FIP3 | 6.87e-05 | 198 | 249 | 10 | 4320_UP |
| Drug | DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A | ZSCAN2 CHPF DOCK6 EPB41L5 ATG3 SAFB2 HMGXB3 CAVIN1 GGA1 RBM34 | 6.87e-05 | 198 | 249 | 10 | 2877_DN |
| Drug | Fusidic Acid | 6.95e-05 | 8 | 249 | 3 | ctd:D005672 | |
| Drug | 3',4',7-trihydroxyisoflavone | 6.95e-05 | 8 | 249 | 3 | ctd:C061213 | |
| Drug | tiagabine | 6.95e-05 | 8 | 249 | 3 | ctd:C059205 | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A | GGA2 ATAD5 SETDB1 DOP1B CACNB3 C9orf40 CEP164 RABL6 SAFB2 ARHGAP45 | 7.17e-05 | 199 | 249 | 10 | 7374_UP |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 7.47e-05 | 200 | 249 | 10 | 5432_UP | |
| Drug | Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | GPRASP1 HECW1 ARHGEF17 PASK KCNS1 RIPOR1 DOCK6 LAMB1 RGS12 MRNIP | 7.47e-05 | 200 | 249 | 10 | 7463_UP |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | ATAD5 ADD3 FBXL18 KATNIP CHPF CACNB3 MICALL2 ACIN1 AKAP13 JRKL | 7.47e-05 | 200 | 249 | 10 | 7165_DN |
| Drug | AC1L85AO | 8.46e-05 | 66 | 249 | 6 | CID000372705 | |
| Drug | exemestane | 1.03e-04 | 43 | 249 | 5 | CID000060198 | |
| Drug | IAARh123 | 1.03e-04 | 9 | 249 | 3 | CID000656577 | |
| Drug | HCFC-123 | 1.05e-04 | 23 | 249 | 4 | CID000009385 | |
| Drug | enkephalin-Leu, Ala(2)-melphalan methyl ester- | 1.19e-04 | 2 | 249 | 2 | ctd:C040240 | |
| Drug | midecamycin | 1.19e-04 | 2 | 249 | 2 | ctd:C026483 | |
| Drug | tasosartan | 1.19e-04 | 2 | 249 | 2 | ctd:C086167 | |
| Drug | Sulfinpyrazone | 1.19e-04 | 2 | 249 | 2 | DB01138 | |
| Drug | heptosyl-2-keto-3-deoxyoctulosonate | 1.19e-04 | 2 | 249 | 2 | CID000127981 | |
| Drug | glutathione-BPDE conjugate | 1.19e-04 | 2 | 249 | 2 | ctd:C113118 | |
| Drug | bromfenac | 1.19e-04 | 2 | 249 | 2 | ctd:C053083 | |
| Drug | robinetin | 1.19e-04 | 2 | 249 | 2 | ctd:C040014 | |
| Drug | Fluo-3 | 1.19e-04 | 2 | 249 | 2 | ctd:C059715 | |
| Drug | 1,9-dideoxyforskolin | 1.19e-04 | 2 | 249 | 2 | ctd:C047983 | |
| Drug | benziodarone | 1.19e-04 | 2 | 249 | 2 | ctd:C058702 | |
| Drug | tipranavir | 1.19e-04 | 2 | 249 | 2 | ctd:C107201 | |
| Drug | benzoylmesaconine | 1.19e-04 | 2 | 249 | 2 | ctd:C085283 | |
| Drug | benzoylaconine | 1.19e-04 | 2 | 249 | 2 | ctd:C047307 | |
| Drug | Phenazopyridine | 1.19e-04 | 2 | 249 | 2 | ctd:D010621 | |
| Drug | azotochelin | 1.19e-04 | 2 | 249 | 2 | CID000193592 | |
| Drug | lithocholyltaurine | 1.38e-04 | 175 | 249 | 9 | CID000010595 | |
| Drug | sulfobromophthalein | 1.40e-04 | 103 | 249 | 7 | CID000005345 | |
| Drug | N-phthaloyl-DL-glutamic acid | 1.47e-04 | 10 | 249 | 3 | CID000004804 | |
| Drug | AC1NN9F1 | 1.47e-04 | 10 | 249 | 3 | CID000000410 | |
| Drug | Endotoxins | 1.47e-04 | 25 | 249 | 4 | ctd:D004731 | |
| Drug | Epirubicin | 1.58e-04 | 47 | 249 | 5 | ctd:D015251 | |
| Drug | 4-epidoxorubicin | MYH3 TRADD ERCC3 MYH13 HECW1 TNFRSF10D ARHGEF17 ABCB1 ABCB4 CSRNP1 MYO3A SAFB TONSL ABCC2 SMG6 ABCC1 TASP1 TGFBI SAFB2 ABCB11 IL1A | 1.67e-04 | 788 | 249 | 21 | CID000001690 |
| Drug | E-guggulsterone | 1.88e-04 | 108 | 249 | 7 | CID006439929 | |
| Drug | prochloraz | ERBB3 CHGA ABCB1 SYNGAP1 PPARGC1A NRXN2 NOTCH3 ABCC1 CACNB3 LAMB1 GRIN1 | 1.90e-04 | 268 | 249 | 11 | ctd:C045362 |
| Drug | physcione | 2.00e-04 | 11 | 249 | 3 | ctd:C008905 | |
| Drug | Sulfinpyrazone | 2.00e-04 | 11 | 249 | 3 | ctd:D013442 | |
| Drug | Z-335 | 2.00e-04 | 11 | 249 | 3 | CID000219052 | |
| Drug | 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 | 2.00e-04 | 11 | 249 | 3 | ctd:C061137 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | TRADD ERCC3 ITPRID2 DOCK6 NOTCH3 DGKD GTF2IRD1 RABL6 RAPGEFL1 | 2.10e-04 | 185 | 249 | 9 | 1049_DN |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.18e-04 | 186 | 249 | 9 | 6793_UP | |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.18e-04 | 186 | 249 | 9 | 5777_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.36e-04 | 188 | 249 | 9 | 6143_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 2.66e-04 | 191 | 249 | 9 | 4289_DN | |
| Drug | LY117018 | 2.67e-04 | 29 | 249 | 4 | CID000104946 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; PC3; HT_HG-U133A | ATAD5 FBXL5 SETDB1 NOTCH3 DESI2 TIGD6 ARHGAP1 CATSPER2 AKAP13 | 2.76e-04 | 192 | 249 | 9 | 6664_DN |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.76e-04 | 192 | 249 | 9 | 6513_UP | |
| Drug | notoginsenoside R1 | 2.82e-04 | 82 | 249 | 6 | ctd:C072936 | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | FBXL5 KATNIP CCDC186 LAMB1 PPP4R3A LPP CAVIN1 RBM34 RAB11FIP3 | 2.87e-04 | 193 | 249 | 9 | 3562_DN |
| Drug | STOCK1N-35215; Down 200; 10uM; MCF7; HT_HG-U133A | TRADD SYT17 ITPRID2 C9orf40 FAM131A SRBD1 DNAAF2 RAPGEFL1 RAB11FIP3 | 2.87e-04 | 193 | 249 | 9 | 6422_DN |
| Drug | Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | PDE4B PCNX2 IMPG2 DSCAM TEX15 ZFYVE26 CTNNA2 INPP5J RAB11FIP3 | 2.87e-04 | 193 | 249 | 9 | 2412_UP |
| Drug | blebbistatin | 2.92e-04 | 116 | 249 | 7 | CID003476986 | |
| Disease | aspartate aminotransferase measurement | KIF21B BDP1 ERBB3 FSTL4 BECN2 BIRC6 ABCB1 ABCB4 PPARGC1A SETDB1 ZSCAN2 ABCC2 CLEC16A NUP160 SMG6 KLHL25 ABCB11 ELF1 AKAP13 HMGXB3 CTNNA2 LRBA ARHGAP45 | 1.81e-06 | 904 | 242 | 23 | EFO_0004736 |
| Disease | distal myopathy (implicated_via_orthology) | 2.07e-06 | 12 | 242 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | total blood protein measurement | NCOA3 TMPRSS5 DYSF NYNRIN CLEC16A IMPG2 SMG6 HYOU1 DGKD ARL15 YWHAB RGS12 NFATC2IP MACF1 ARHGAP45 | 5.22e-06 | 449 | 242 | 15 | EFO_0004536 |
| Disease | Lissencephaly | 1.07e-05 | 6 | 242 | 3 | C0266463 | |
| Disease | laurylcarnitine measurement | 1.86e-05 | 7 | 242 | 3 | EFO_0021041 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.04e-05 | 139 | 242 | 8 | DOID:3908 (is_implicated_in) | |
| Disease | Intellectual Disability | UROC1 SYNGAP1 KMT2C NRXN2 ZCCHC8 GRIN1 YWHAG RABL6 FRY ACIN1 MACF1 FUCA1 CTNNA2 HTT | 2.21e-05 | 447 | 242 | 14 | C3714756 |
| Disease | Colorectal Carcinoma | EPHB6 ERCC6 FSTL5 ABCB1 ABCB4 KMT2C FAT1 CSRNP3 ABCD4 ABCC2 DNAH8 ABCC1 FLNC ANK2 ABCB11 ACIN1 LGR6 JPH3 | 2.25e-05 | 702 | 242 | 18 | C0009402 |
| Disease | Malignant neoplasm of breast | NCOA3 ERBB3 ERCC3 ERCC6 DYSF FSCB ABCB1 CNGA2 HSD17B8 NOTCH3 PGBD3 ABCC1 ANK2 FAM131A GSN PPARGC1B ABCB8 MACF1 ZFYVE26 CAVIN1 LGR6 LRBA GGA1 | 2.90e-05 | 1074 | 242 | 23 | C0006142 |
| Disease | Cholestasis of pregnancy | 2.96e-05 | 8 | 242 | 3 | C0268318 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 4.41e-05 | 9 | 242 | 3 | DOID:1485 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 4.41e-05 | 9 | 242 | 3 | DOID:13580 (implicated_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 5.06e-05 | 49 | 242 | 5 | DOID:13580 (biomarker_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 5.18e-05 | 80 | 242 | 6 | DOID:12930 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 6.27e-05 | 10 | 242 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 6.27e-05 | 10 | 242 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 6.27e-05 | 10 | 242 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 6.27e-05 | 10 | 242 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 6.27e-05 | 10 | 242 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 6.27e-05 | 10 | 242 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 6.27e-05 | 10 | 242 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 6.27e-05 | 10 | 242 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | magnesium:creatinine ratio measurement | 6.70e-05 | 2 | 242 | 2 | EFO_0008449 | |
| Disease | Colorectal Neoplasms | 1.05e-04 | 277 | 242 | 10 | C0009404 | |
| Disease | serum alanine aminotransferase measurement | ERBB3 RAD18 PSD ABCB1 ABCB4 NRXN2 NYNRIN ABCC2 NUP160 DAGLB HYOU1 ZCCHC8 ARL15 RGS12 ABCB11 UNK ELF1 HTT NOS1AP | 1.12e-04 | 869 | 242 | 19 | EFO_0004735 |
| Disease | myotonia congenita (implicated_via_orthology) | 1.13e-04 | 12 | 242 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.17e-04 | 31 | 242 | 4 | C1335167 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.47e-04 | 13 | 242 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | ABCB1 ABCB4 PPARGC1A NYNRIN ABCC2 RGS12 ABCB11 HMGXB3 ARHGAP45 | 1.70e-04 | 239 | 242 | 9 | EFO_0010934 |
| Disease | neutrophil count | RIPOR2 MYO1C TSPOAP1 NAIP DGKH ITPKA DRG1 DOCK6 NUP160 MTRF1L SMG6 DAGLB RETREG2 DSCAM ANKRD11 STYXL1 MRNIP AKAP13 LRBA IL1A ARHGAP45 SNX2 HTT NOS1AP RAPGEFL1 | 1.92e-04 | 1382 | 242 | 25 | EFO_0004833 |
| Disease | Progressive intrahepatic cholestasis (disorder) | 2.00e-04 | 3 | 242 | 2 | C0268312 | |
| Disease | Progressive familial intrahepatic cholestasis type 3 | 2.00e-04 | 3 | 242 | 2 | cv:C1865643 | |
| Disease | Cholestasis, benign recurrent intrahepatic 1 | 2.00e-04 | 3 | 242 | 2 | C4551899 | |
| Disease | FEV/FEC ratio | ERBB3 KIAA0232 DZIP1L ARHGEF17 ADD3 PPARGC1A FREM2 RIPOR1 MGA CLEC16A SMG6 COL6A3 TASP1 EPB41L5 DGKD GTF2IRD1 FRMD4A PPARGC1B MICU3 KLHL25 ANKRD11 JPH3 RAPGEFL1 | 2.13e-04 | 1228 | 242 | 23 | EFO_0004713 |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.30e-04 | 15 | 242 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.70e-04 | 152 | 242 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.98e-04 | 71 | 242 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Ciliopathies | 3.01e-04 | 110 | 242 | 6 | C4277690 | |
| Disease | mean platelet volume | CFAP251 MYO1C ATAD5 KIAA0232 FBXL18 KCNS1 RIPOR1 DAGLB YWHAB RGS12 FRY ANKRD11 INTS4 STYXL1 CAVIN1 ARHGAP45 SNX2 HTT NOS1AP RAB11FIP3 | 3.10e-04 | 1020 | 242 | 20 | EFO_0004584 |
| Disease | intellectual disability (implicated_via_orthology) | 3.85e-04 | 75 | 242 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | Schizophrenia | ERBB3 PDE4B PSD CHGA ABCB1 SYNGAP1 PPARGC1A SETDB1 NRXN2 TRPM1 MAGEC1 RETREG2 LMOD2 RGS12 GSN ARHGAP1 CTNNA2 NOS1AP | 3.94e-04 | 883 | 242 | 18 | C0036341 |
| Disease | intrahepatic cholestasis (is_implicated_in) | 3.98e-04 | 4 | 242 | 2 | DOID:1852 (is_implicated_in) | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 3.98e-04 | 4 | 242 | 2 | C4551898 | |
| Disease | hereditary spastic paraplegia 12 (implicated_via_orthology) | 3.98e-04 | 4 | 242 | 2 | DOID:0110765 (implicated_via_orthology) | |
| Disease | serum albumin measurement | WDR81 ADGRV1 DYSF NYNRIN ALDH16A1 MIA3 EPB41L5 ARL15 YWHAB RGS12 FRY CATSPER2 MACF1 GGA1 | 4.17e-04 | 592 | 242 | 14 | EFO_0004535 |
| Disease | Manic | 4.62e-04 | 78 | 242 | 5 | C0338831 | |
| Disease | cutaneous melanoma | 5.01e-04 | 121 | 242 | 6 | EFO_0000389 | |
| Disease | creatinine measurement | KIF21B DGKH ADGRV1 BIRC6 PPARGC1A NRXN2 TMEM266 EBNA1BP2 CFAP70 PLEKHH2 DSCAM EPB41L5 ARL15 RGS12 FRY MICALL2 LPP ANKRD11 STYXL1 | 6.04e-04 | 995 | 242 | 19 | EFO_0004518 |
| Disease | urate measurement, bone density | FSTL5 FSIP2 PPARGC1A USH2A DNAH8 UTRN DSCAM DGKD LPP USP40 ANKRD11 CTNNA1 CTNNA2 JPH3 | 6.46e-04 | 619 | 242 | 14 | EFO_0003923, EFO_0004531 |
| Disease | myopathy (implicated_via_orthology) | 6.47e-04 | 48 | 242 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | muscular dystrophy (implicated_via_orthology) | 6.50e-04 | 21 | 242 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | Pachygyria | 6.59e-04 | 5 | 242 | 2 | C0266483 | |
| Disease | Agyria | 6.59e-04 | 5 | 242 | 2 | C1879312 | |
| Disease | thalamus volume | 6.85e-04 | 85 | 242 | 5 | EFO_0006935 | |
| Disease | alopecia areata | 7.56e-04 | 50 | 242 | 4 | EFO_0004192 | |
| Disease | Squamous cell carcinoma of the head and neck | 8.77e-04 | 52 | 242 | 4 | C1168401 | |
| Disease | nevus count, cutaneous melanoma | 9.33e-04 | 91 | 242 | 5 | EFO_0000389, EFO_0004632 | |
| Disease | foot muscle strength measurement | 9.83e-04 | 6 | 242 | 2 | EFO_0009699 | |
| Disease | Cockayne syndrome (implicated_via_orthology) | 9.83e-04 | 6 | 242 | 2 | DOID:2962 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | RIPOR2 REXO1 ABCB4 SAFB AK5 NYNRIN TONSL ABCC1 RETREG2 PPP4R3A TIGD6 ATF7IP INTS4 ELF1 AKAP13 NOS1AP | 9.93e-04 | 799 | 242 | 16 | EFO_0010701 |
| Disease | Neurodevelopmental Disorders | 1.03e-03 | 93 | 242 | 5 | C1535926 | |
| Disease | Liver carcinoma | UROC1 PTH1R ABCB1 ABCB4 CSRNP1 KMT2C FBXL18 TONSL ERP29 NOTCH3 CDCA8 ZWINT | 1.06e-03 | 507 | 242 | 12 | C2239176 |
| Disease | JT interval | 1.07e-03 | 248 | 242 | 8 | EFO_0007885 | |
| Disease | Nasal Cavity Polyp | 1.08e-03 | 55 | 242 | 4 | EFO_1000391 | |
| Disease | femoral neck bone mineral density | 1.22e-03 | 196 | 242 | 7 | EFO_0007785 | |
| Disease | upper face morphology measurement | 1.24e-03 | 97 | 242 | 5 | EFO_0010949 | |
| Disease | glucose measurement | PDE4B SYNGAP1 MYO3A PLEKHH2 NUP160 YWHAB ARHGAP1 ABCB11 STYXL1 RAB11FIP3 | 1.26e-03 | 380 | 242 | 10 | EFO_0004468 |
| Disease | Alzheimer disease, APOE carrier status | 1.30e-03 | 98 | 242 | 5 | EFO_0007659, MONDO_0004975 | |
| Disease | hepatocyte growth factor activator measurement | 1.37e-03 | 7 | 242 | 2 | EFO_0008152 | |
| Disease | alpha fetoprotein measurement | 1.42e-03 | 100 | 242 | 5 | EFO_0010583 | |
| Disease | neutrophil percentage of leukocytes | RIPOR2 TSPOAP1 ATAD5 DGKH ITPKA CLEC16A NUP160 DAGLB ELF1 AKAP13 IL1A ARHGAP45 HTT | 1.70e-03 | 610 | 242 | 13 | EFO_0007990 |
| Disease | placental insufficiency (biomarker_via_orthology) | 1.82e-03 | 8 | 242 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | glycocholate measurement | 1.88e-03 | 30 | 242 | 3 | EFO_0010491 | |
| Disease | alkaline phosphatase measurement | RIPOR2 WDR81 MYO3A ATRIP CSRNP3 NYNRIN TONSL PLEKHH2 UTRN NUP160 GSN CATSPER2 ATF7IP ABCB11 MACF1 ELF1 AKAP13 LRBA | 1.90e-03 | 1015 | 242 | 18 | EFO_0004533 |
| Disease | Bipolar Disorder | ERBB3 PDE4B FSTL5 DGKH ADD3 STARD9 DNAH8 DSCAM GRIN1 YWHAH YWHAZ | 2.08e-03 | 477 | 242 | 11 | C0005586 |
| Disease | Huntington's disease (implicated_via_orthology) | 2.27e-03 | 32 | 242 | 3 | DOID:12858 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 2.32e-03 | 9 | 242 | 2 | EFO_0004606 | |
| Disease | Disease Exacerbation | 2.48e-03 | 165 | 242 | 6 | C0235874 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 2.63e-03 | 115 | 242 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | asthma, age at onset | 2.65e-03 | 70 | 242 | 4 | EFO_0004847, MONDO_0004979 | |
| Disease | lymphocyte:monocyte ratio | 2.73e-03 | 288 | 242 | 8 | EFO_0600088 | |
| Disease | eosinophil count | MON2 ERBB3 SYT17 KIAA0232 DGKH DYSF ADD3 ITPKA CLEC16A SH3TC2 RANBP6 PELP1 ATF7IP LPP ANKRD11 STYXL1 UNK ELF1 AKAP13 FUCA1 ARHGAP45 ZRANB1 RAPGEFL1 | 2.77e-03 | 1488 | 242 | 23 | EFO_0004842 |
| Disease | Manic Disorder | 2.79e-03 | 71 | 242 | 4 | C0024713 | |
| Disease | neutrophil percentage of granulocytes | 2.87e-03 | 228 | 242 | 7 | EFO_0007994 | |
| Disease | X-21448 measurement | 2.89e-03 | 10 | 242 | 2 | EFO_0800816 | |
| Disease | urate measurement | RIPOR2 ADGRV1 DYSF BIRC6 REXO1 PTH1R OAF NRXN2 AK5 ALDH16A1 TMEM266 LMTK2 ARL15 SLC12A1 MICALL2 AKAP13 | 3.10e-03 | 895 | 242 | 16 | EFO_0004531 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.19e-03 | 36 | 242 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | diabetic nephropathy, type 2 diabetes mellitus | 3.51e-03 | 11 | 242 | 2 | EFO_0000401, MONDO_0005148 | |
| Disease | age at menopause | 3.64e-03 | 302 | 242 | 8 | EFO_0004704 | |
| Disease | urinary albumin to creatinine ratio | 3.70e-03 | 179 | 242 | 6 | EFO_0007778 | |
| Disease | interleukin 10 measurement | 3.92e-03 | 78 | 242 | 4 | EFO_0004750 | |
| Disease | hemoglobin A1 measurement | 4.00e-03 | 520 | 242 | 11 | EFO_0007629 | |
| Disease | Depression, Bipolar | 4.10e-03 | 79 | 242 | 4 | C0005587 | |
| Disease | heat shock protein beta-1 measurement | 4.19e-03 | 12 | 242 | 2 | EFO_0010595 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4.19e-03 | 12 | 242 | 2 | C0023485 | |
| Disease | heart failure | 4.34e-03 | 185 | 242 | 6 | EFO_0003144 | |
| Disease | Nonsyndromic Deafness | 4.48e-03 | 81 | 242 | 4 | C3711374 | |
| Disease | QT interval | PDE4B KIAA0232 ITPKA PPARGC1A NUP160 ABCC1 RANBP6 DGKD USP40 JPH3 NOS1AP | 4.86e-03 | 534 | 242 | 11 | EFO_0004682 |
| Disease | allergic rhinitis | 4.89e-03 | 133 | 242 | 5 | EFO_0005854 | |
| Disease | amygdala volume | 4.92e-03 | 13 | 242 | 2 | EFO_0006934 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDPVAESSEEVEAAS | 21 | Q8N6Y0 | |
| AREAAELEEASAESE | 156 | Q9UKV3 | |
| ELLETTSESNLEDSI | 366 | Q13075 | |
| FDDAIAELDTLNEDS | 201 | P61981 | |
| ELAAESDVSTAIDLF | 381 | Q15582 | |
| EELELAVLEAGSSEA | 376 | Q96QE3 | |
| VSVSSTDSLDEDRID | 296 | Q86US8 | |
| LDLDLEAEEDNLATT | 1011 | P21860 | |
| LDGTADDATTVDTLL | 341 | Q6PJG6 | |
| TAFDEAIAELDTLNE | 196 | P31946 | |
| FDEAIAELDTLNEDS | 196 | P27348 | |
| AEDGSIILDEESLTV | 251 | A6H8Y1 | |
| EIDLSVLEDDTSAVA | 241 | Q96KC9 | |
| VLEDDTSAVATLTDS | 246 | Q96KC9 | |
| VSASEDLLEEIESEL | 156 | Q7Z3E2 | |
| ITESSLDVAEEEIID | 61 | P32519 | |
| VLDSASSEDDLEAAR | 106 | Q9NXU5 | |
| ILSDTSDEEDASVTV | 406 | Q6UB99 | |
| DDIDEADILVDGSLS | 971 | Q9NR09 | |
| AAALELSSDEAVEVE | 196 | Q6NZI2 | |
| RESLDLSEVSEVESN | 401 | Q96P56 | |
| SLDSDVSLEEDRESA | 26 | P54284 | |
| ESLLLLTDTADVDSA | 276 | Q8IZ83 | |
| FDDAIAELDTLNEDS | 201 | Q04917 | |
| SEDSAVVLSLIDTID | 341 | Q6QNK2 | |
| LEDAEQELLSDDASS | 576 | Q9UEY8 | |
| LAENSASSDDLLVAE | 76 | P30040 | |
| ASSDDLLVAEVGISD | 81 | P30040 | |
| DSLVSLSEEDLESDQ | 1641 | Q12802 | |
| EITIIDDAEFELTET | 3986 | Q8WXG9 | |
| LLDEATSALDTESEK | 1241 | O95342 | |
| ATSDEEDSVLSIARE | 1031 | A6QL64 | |
| EERDLLSDLQDISDS | 271 | P21127 | |
| ALADTVATTSTELDE | 1536 | Q8TDJ6 | |
| VLDEATSALTEEVES | 546 | O14678 | |
| DQEEDSDILTSSEAL | 1211 | Q9P1Z9 | |
| EDFSALSLESANVED | 531 | Q7Z478 | |
| ELEEAEDAAASASVA | 166 | Q9BSY9 | |
| EESGLLETDEATLDT | 161 | Q9NT62 | |
| EDAETDELLRDLSTQ | 141 | Q8TBY9 | |
| DRESALASADLEEEI | 121 | P42696 | |
| SSSSDIIRDLLEEEE | 441 | Q9NS91 | |
| DITLSSEEEAEVAAP | 466 | Q3YEC7 | |
| ASEVDDLEPDSVSLA | 806 | A6NNM3 | |
| ASEVDDLEPDSVSLA | 806 | A6NJZ7 | |
| DTASEVEELEADSVS | 626 | O95153 | |
| ESLAAEISSVSRDEL | 706 | O75154 | |
| EDQLDTVLAVLEDSS | 446 | Q96HW7 | |
| LTDLFAQLTDEATDE | 311 | Q6IN85 | |
| ILLLDEATSALDTES | 551 | P08183 | |
| ILLLDEATSALDTES | 1196 | P08183 | |
| LTEDENTSDSDIILV | 716 | Q86VD1 | |
| LRSLEETVSASEEEN | 71 | Q6NTE8 | |
| LDVEAAADEEAATLA | 1586 | Q96PE2 | |
| RDSEVLSAVADDSLA | 2416 | Q01484 | |
| SEDESDLEISSLEDL | 716 | Q8IYY4 | |
| HEITDLLETDDSIEA | 476 | P0DP91 | |
| VIAILSTTDADSEEI | 2936 | Q14517 | |
| SSDNSDLEDDIILSL | 1491 | Q9Y4B6 | |
| SITDDDLEAIANDSE | 91 | P01583 | |
| FLRSDSDVVEALSEE | 171 | Q96RG2 | |
| LADISEVLNTDDDIL | 1431 | Q8NEZ4 | |
| DSDLEEASELLSSSE | 1031 | Q92619 | |
| LESDSLTDSESLIES | 886 | O60732 | |
| AVSVLDSADIEVTDS | 66 | Q9H6Y5 | |
| LRSDATADDLIDVVE | 221 | Q9Y295 | |
| SLASSEDETEITEDL | 1056 | Q68CZ1 | |
| ALLNTDIDIDSLEAD | 116 | P46199 | |
| TSAIEEAALDSSELL | 2796 | Q8IWI9 | |
| EDDTDETLTSLLNEI | 2816 | Q8IWI9 | |
| PLAEETTAEEASAEI | 511 | Q5H9T9 | |
| IESDTDLSETAELIE | 106 | Q9Y6K8 | |
| ASSSLEDLDLSGEEV | 6 | Q9NVR5 | |
| SDSDLVSLTVDVDSL | 161 | Q96S38 | |
| VSLTVDVDSLAELDD | 166 | Q96S38 | |
| VAFSDVDLILEASEA | 871 | Q9HBX8 | |
| VVDAIDDASVEEDLA | 171 | Q96S65 | |
| SEVDTVAADPSALEE | 601 | Q76N89 | |
| GDTILFTTDDDILEA | 1121 | O60303 | |
| SFSSDEEADLELQAL | 1191 | Q9Y3R5 | |
| TTLTGEEDIDDIADL | 3476 | Q2LD37 | |
| AEAQLESDDDVLLVA | 46 | Q8IYD8 | |
| SAEDVDSLNDDILCT | 1091 | Q5SZK8 | |
| IDEDELLASLSAEEL | 16 | Q6P5Q4 | |
| QALEEAATADLDITE | 81 | Q53HL2 | |
| ESASEDIELESLEDF | 76 | P0C7V8 | |
| EEASTLTLDDISDDD | 146 | Q8WYN3 | |
| LESLVTSIDDDILAS | 1341 | Q5CZC0 | |
| TSEILSQDVLLEDAS | 206 | Q12766 | |
| STVNDRSDIVDSLDE | 846 | Q8IY33 | |
| SESDESLVTDRELQD | 11 | Q99848 | |
| EVDSSDSEVAVTLID | 346 | A6NKB5 | |
| SDLTSEAVEELSESV | 431 | Q92628 | |
| RDSLGETDIDIATED | 716 | Q07343 | |
| ELLETLITTEASDDS | 3976 | Q96JB1 | |
| LDKSDDSDSSLSEVL | 1266 | O75037 | |
| SEAGEAELTIEILSD | 1181 | Q14315 | |
| ALSDVTEESEIISEL | 311 | P04066 | |
| FLATGDSEILDLESE | 611 | Q9P2S2 | |
| DEADDTSASIISDLI | 1811 | Q9UM47 | |
| ASIVSLEEEDVTAAA | 886 | O94854 | |
| SLDAEIDSLTSILAD | 116 | Q93052 | |
| DDLEVSSDIIEAVAI | 1046 | P50851 | |
| LTQDSADLDSIEAVA | 1511 | P07942 | |
| ALRSVELEESSTDED | 591 | Q8IWU2 | |
| EETLRLTESDSVLAD | 891 | Q8IWU2 | |
| LTESDSVLADDILAS | 896 | Q8IWU2 | |
| LASDTEDNDEALAEI | 266 | Q9UJY5 | |
| RLASDTTDDDDALAE | 281 | Q9UJY4 | |
| EFEDLLSSIDGVSEA | 481 | Q96KK3 | |
| DEATAAVDLETDNLI | 1461 | Q92887 | |
| ESLDFDVEDISVATV | 396 | Q9Y4A0 | |
| LAERADDITSLVTDT | 326 | Q86XE3 | |
| SLLLDASTDEAATEN | 566 | Q7Z3U7 | |
| DEVDLSDASVAEAST | 106 | Q86XP1 | |
| SDSESVDLELSNLEI | 21 | Q9H579 | |
| VEISLESDSDDSVVI | 776 | Q8IZL8 | |
| AETVELLREASAESD | 631 | P28290 | |
| ETDLDLVDGDSTEVL | 486 | Q8IVE3 | |
| VDEDISSLFVEDSAR | 421 | Q8N475 | |
| SSLLEDSEDDLLSDS | 131 | P23677 | |
| LDEATSALDTESEAE | 556 | P21439 | |
| SALDTESEAEVQAAL | 561 | P21439 | |
| LDLSELDVNDLDTDS | 36 | Q9UBK2 | |
| ELATSEDEAAALRAE | 151 | A8MW95 | |
| EDSSLSDALVLEDED | 541 | Q9P2Q2 | |
| SDALVLEDEDSQVTS | 546 | Q9P2Q2 | |
| EEGSSEDLLELSDVD | 401 | Q96EP1 | |
| EDLLELSDVDSESSD | 406 | Q96EP1 | |
| ATDELDALLASLTEN | 631 | Q9HCM4 | |
| ETLVEDSAEEESTLT | 561 | Q9Y4L1 | |
| DLTSSATDGDEEDIL | 516 | P42858 | |
| DTLLDLISSDELETE | 191 | Q9H0H3 | |
| SSNVLEESAISDDIL | 1651 | Q96HP0 | |
| ALSALDNTIEDDADD | 26 | Q6ZS62 | |
| LTEAVDDITSVDDFL | 496 | P26232 | |
| RVLTDAVDDITSIDD | 496 | P35221 | |
| DLVTDEETASDALER | 216 | O95727 | |
| DVLTDLSAESEVLDV | 381 | Q8NCG7 | |
| LEELTEAEDALSEAN | 1046 | Q5T0N1 | |
| EDVADVVAFLASEDS | 231 | Q92506 | |
| VDEDISSLFIEDSAR | 421 | Q6MZW2 | |
| ESDAADIVFLIDSSE | 1431 | P12111 | |
| TSREEDEVALAADLE | 751 | Q8N1P7 | |
| SDLASSGVVSLDEDE | 346 | Q6UXB0 | |
| ADDIASSEITSVDLA | 226 | Q6VMQ6 | |
| SDDLATGELASDELT | 266 | Q6VMQ6 | |
| IIFDEVDLTDASVAE | 91 | Q16760 | |
| SEISDSLDVLEAGDE | 146 | Q9ULL0 | |
| IIDDVDSFLAAAETL | 271 | O60256 | |
| DEVAASAILTAQLDE | 501 | P06396 | |
| ESEESAEESIAISIA | 296 | Q9UKA1 | |
| ATADDAETSEATEII | 646 | Q66K89 | |
| VLAATDLDAEEEVVA | 716 | P19447 | |
| ESSEEEDLTASQILE | 2521 | Q5TBA9 | |
| TADDLEELDTLASQA | 56 | Q8WXE1 | |
| ADIEDLSEDTLTEAT | 166 | Q8IXQ3 | |
| ERASTATAEETDIDA | 206 | O75052 | |
| EDTSAEVSRATVLDL | 451 | Q9UHL9 | |
| LSEAEIEEELSSAAN | 681 | Q6ZTR5 | |
| STEDVDSLVAQLTDE | 701 | O75923 | |
| ELSELEDRVAVTASE | 461 | Q9BV36 | |
| TEDAELAEAAENSLL | 526 | Q96LW4 | |
| EDDLDSSLASVFRVE | 1016 | Q9P2P1 | |
| TDLLETDDSIEASAI | 11 | Q8N328 | |
| TVLILDEATSALDAE | 631 | Q9NUT2 | |
| DEATSALDAESERVV | 636 | Q9NUT2 | |
| LVLDEATAAVDLETD | 1451 | P33527 | |
| ATAAVDLETDDLIQS | 1456 | P33527 | |
| ETIDDRSTVLLTDAD | 1676 | O60469 | |
| AEATSESILAADDEQ | 481 | Q5JY77 | |
| IDDSSPEDLIAAFTE | 646 | O95197 | |
| ELDSELIIESCDASS | 461 | Q16799 | |
| SLEETEESIDALVSS | 356 | Q8TDW5 | |
| AESTGLELSDEVAAL | 21 | Q9Y6J9 | |
| TEADLADTSVTLRDV | 1111 | Q8N1G1 | |
| CTVSEASEALTDEDI | 2226 | O75445 | |
| TDAVNEALESLESVL | 1266 | P46939 | |
| EDLFAEATEEVSLDS | 71 | O60749 | |
| LSEDALVLSSEEGAA | 41 | Q13884 | |
| VTADDDLIISQDTDI | 421 | Q17RP2 | |
| VSDSDSELDSTERLA | 526 | A5PKW4 | |
| LLEEEVEFSTDLIDS | 291 | Q7Z6K3 | |
| VEALEENELTSLAED | 286 | Q15628 | |
| SNSDDVDSLTDEEIL | 166 | Q9BSW7 | |
| STADALVSDDETTRL | 281 | Q5JRA6 | |
| ASEVDDLEPDSVSLA | 806 | Q9UFD9 | |
| SEETDENDLILEVTA | 121 | Q9UGC7 | |
| TVESLDDAEELLATE | 331 | Q9Y2K3 | |
| AEDDIDSSILETLVA | 366 | Q96ME1 | |
| ALEEVLLDTTGETSE | 31 | O15197 | |
| EELAELISANLSDID | 46 | Q9Y6Q9 | |
| LALAITDSELSDEEA | 301 | Q8NC44 | |
| TDSELSDEEASILES | 306 | Q8NC44 | |
| ELQDDLTLDDTSEAL | 6 | Q07960 | |
| ELDLSQLDASDFDSA | 41 | Q86YN6 | |
| NSDVTISDIDAEDVL | 161 | Q9P2F8 | |
| ISDSDDDDDERILSL | 1016 | Q7Z333 | |
| VSALDNALELTTVED | 661 | Q13621 | |
| SSEDSSLEEELLSAT | 421 | Q8TF17 | |
| VASIDDAEELLATDS | 321 | P11055 | |
| DAEELLATDSAIDIL | 326 | P11055 | |
| EESLATAEVNSSDAL | 101 | B1ATL7 | |
| LEDEASALRLDEDSE | 431 | Q9Y4P8 | |
| SFSLDSLIDAEEELG | 1201 | Q9P2P6 | |
| LANVEESEDFLSIDS | 516 | Q9BZV3 | |
| VSVDLVTDSDEEILE | 46 | Q8NCF5 | |
| LTEDETTISDDVDIA | 586 | Q12769 | |
| DDSVLESLVEIADTV | 241 | O60518 | |
| ESLQADSDADSISLE | 46 | Q86UD1 | |
| ELNSSVAIADTALED | 86 | Q8N5C6 | |
| DVAEALLQESEEASE | 536 | Q9Y4F9 | |
| ELAEASSEELAEAPT | 326 | Q15424 | |
| DAATATVESEEIAEL | 11 | Q15047 | |
| FDEAIAELDTLSEES | 196 | P63104 | |
| EAEELGEDSAASLSL | 506 | Q9UPV0 | |
| DQELESLSAIEAELE | 431 | P10645 | |
| LAAASEQEEELLESL | 691 | Q8IZ52 | |
| EDTADTLSVESLTLV | 996 | Q2KHT3 | |
| AADDDTSSELQRLAD | 41 | Q16280 | |
| ADISTLLDASATLEE | 341 | Q9UBN6 | |
| LDDSTVARELAITDS | 271 | Q86VR2 | |
| TSSEGEDDSTLELLA | 856 | Q15735 | |
| DLSVSEDDLLIEVSE | 266 | Q8WWB5 | |
| NASALTELSDLEVLD | 546 | Q9NR97 | |
| TEAEAAALEVLAEVA | 6 | O95229 | |
| IDTSADAVEDLTEAE | 286 | A6PVC2 | |
| ASGAVDEDALTLEEL | 506 | Q6NZY4 | |
| ESSEEAAALVEDLTQ | 116 | Q7Z7L9 | |
| SLDDLESATVSDGEL | 661 | O14924 | |
| SSTLEILLKDDDDDS | 81 | Q9Y6J8 | |
| SAAEALELNLDEDSI | 191 | Q96PV0 | |
| LESAQSEEEVDELSL | 656 | Q13905 | |
| SGATLDEAERLTEEE | 246 | Q03431 | |
| VRASLSDLSSLDDVE | 251 | Q969K3 | |
| LAVTDELATSVLEEA | 461 | Q96N76 | |
| AEEAAATAESEALEA | 471 | Q96HA7 | |
| DEEITLSCSEASAEE | 86 | Q9H3S3 | |
| ADTADFDVAVLELTS | 286 | Q7Z410 | |
| TVASIDDSEELLATD | 321 | Q9UKX3 | |
| DDSEELLATDNAIDI | 326 | Q9UKX3 | |
| SAASELAEASSEELA | 321 | Q14151 | |
| LAEASSEELAEAPTE | 326 | Q14151 | |
| SSESDLVDDISQDLD | 656 | Q7Z4N2 | |
| TLDDSDEDVILVVSL | 271 | P0CG32 | |
| SVSREVSLELSEEDS | 1266 | Q5VWN6 | |
| VSLELSEEDSDIDLA | 1271 | Q5VWN6 | |
| RFADDILETSADSLE | 641 | Q14139 | |
| DNAVSAATALLESEE | 546 | Q9BXT5 | |
| AATALLESEEDTISA | 551 | Q9BXT5 | |
| AAISLISEEEDDTSS | 151 | Q96NL1 | |
| ATRDSAASDILLDDI | 166 | Q9UHV5 | |
| VESVIESALDDLDLN | 511 | Q9C0B0 | |
| SEASVDAALAEASVE | 456 | Q6ZS17 | |
| LLDQEAASTADLTDS | 106 | Q9NVE5 | |
| DSEDEASRLLAADAL | 46 | A8MYJ7 | |
| ISSDEDGIADLERET | 301 | Q69YN4 | |
| DVLSEAFEESLVARD | 1411 | Q68DK2 | |
| LATDAVTAALVELED | 81 | Q9H6P5 | |
| DPELEEALASASDTE | 116 | Q9NZR1 | |
| EDDLEQATEALDSIS | 656 | Q562E7 | |
| DSEELSSLQVLDADT | 176 | Q6P4I2 | |
| EAIELAETEEASSII | 181 | Q9UGI0 | |
| EEATVQDLLSSLSED | 436 | Q2M3C6 | |
| AELAVIEDDIDATTT | 271 | Q8WXH2 | |
| ADLEAVLESSEEEIL | 1116 | Q9Y6N6 | |
| EADLTEETEENLRSS | 606 | Q5T7N2 | |
| FTEDEVEDLLSIVAS | 296 | O00159 | |
| DDLATLEILDENTVS | 341 | Q8NEV4 | |
| VSDDLSETDISNEAR | 556 | Q8NFW9 | |
| VNSEEEEEDALTLSS | 591 | Q05586 |